BCG vaccine 1977 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against tuberculosis 1 L03AX03 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/205 Ebola vaccine 2025 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BX02 All vaccines should comply with the WHO requirements for biological substances. false false https://list.essentialmeds.org/medicines/953 Japanese encephalitis vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BA02, J07BA03 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/436 Medicines for COVID-19 2023 Medicines for COVID-19 Medicines for COVID-19 1 COVID-19 1 Refer to WHO living guidelines false false https://list.essentialmeds.org/medicines/905 abacavir 2002 Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AF06 Oral > Solid: 300 mg tablet (as sulfate) false false https://list.essentialmeds.org/medicines/315 abacavir + dolutegravir + lamivudine 2025 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR13 Oral > Solid > tablet: 60 mg (as sulfate) + 5 mg + 30 mg (dispersible, scored) false false https://list.essentialmeds.org/medicines/947 abacavir + lamivudine 2015 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR02 Oral > Solid: 120 mg (as sulfate) + 60 mg tablet (dispersible, scored) false false https://list.essentialmeds.org/medicines/316 abiraterone 2019 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of prostate 1 L02BX03 Oral > Solid: 250 mg; 500 mg true false https://list.essentialmeds.org/medicines/406 acamprosate calcium 2023 Medicines for alcohol use disorders Medicines for alcohol use disorders 1 Disorders due to use of alcohol 1 N07BB03 Oral > Solid > tablet: 333 mg false false https://list.essentialmeds.org/medicines/908 acenocoumarol 2025 Medicines affecting coagulation Medicines affecting coagulation 1 Venous thromboembolism; Cerebral ischaemic stroke due to embolic occlusion; Atrial fibrillation; Other specified diseases of arteries or arterioles 4 false false https://list.essentialmeds.org/medicines/979 acetazolamide 1977 Ophthalmological preparations > Miotics and antiglaucoma medicines Ophthalmological preparations > Miotics and antiglaucoma medicines 1 Primary open-angle glaucoma 1 S01EC01 Oral > Solid: 250 mg false false https://list.essentialmeds.org/medicines/234 acetic acid 2009 Ear, nose and throat medicines [c] Ear, nose and throat medicines [c] 1 Infectious diseases of external ear 1 S02AA10 Local > Otological > drops: 2% solution false false https://list.essentialmeds.org/medicines/270 acetylcysteine 1999 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs 1 V03AB23 Parenteral > General injections > IV: 200 mg per mL in 10 mL ampoule Oral > Liquid: 10%; 20% false false https://list.essentialmeds.org/medicines/36 acetylsalicylic acid 1977 Medicines for acute migraine attacks Medicines for acute migraine attacks; Anti-platelet medicines; Medicines for juvenile joint diseases; Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) 4 Migraine; Acute myocardial infarction; Cerebral ischaemic stroke; Mucocutaneous lymph node syndrome; Juvenile idiopathic arthritis; Acute rheumatic fever without mention of heart involvement; Pain 7 N02BA01, B01AC06 Oral > Solid: 300 to 500 mg; Oral > Solid: 100 mg; Local > Rectal > Suppository: 150 mg; 300 mg Oral > Solid > dispersible tablet: 75 mg; 300 mg; 500 mg Oral > Solid > tablet: 75 to 500 mg; Oral > Solid: 100 to 500 mg Local > Rectal > Suppository: 50 to 150 mg false false https://list.essentialmeds.org/medicines/13 acetylsalicylic acid + atorvastatin + ramipril 2023 Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease 1 Atherosclerotic chronic arterial occlusive disease; Chronic ischaemic heart disease; Cerebral ischaemic stroke 3 C10BX06 Oral > Solid > tablet: 100 mg + 20 mg + 2.5 mg; 100 mg + 20 mg + 5 mg; 100 mg + 20 mg + 10 mg; 100 mg + 40 mg + 2.5 mg; 100 mg + 40 mg + 5 mg; 100 mg + 40 mg + 10 mg false false https://list.essentialmeds.org/medicines/910 acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide 2023 Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease 1 Atherosclerotic chronic arterial occlusive disease; Chronic ischaemic heart disease; Cerebral ischaemic stroke 3 Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg false false https://list.essentialmeds.org/medicines/911 aciclovir 1997 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents; Antiherpes medicines; Medicines for viral central nervous system infections 3 Herpes simplex keratitis; Zoster; Herpes simplex infections; Varicella 4 S01AD03, J05AB01 Local > Ophthalmological > Ointment: 3% w/w; Parenteral > General injections > IV: 250 mg in vial powder for solution for infusion (as sodium dihydrate); 25 mg per mL in vial solution for infusion (as sodium) Oral > Liquid: 200 mg per 5 mL Oral > Solid: 200 mg tablet Parenteral > General injections > IV: 250 mg in vial powder for solution for infusion (as sodium diihydrate); 25 mg per mL in vial solution for infusion (as sodium) false false https://list.essentialmeds.org/medicines/226 aclidinium 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease 1 false false https://list.essentialmeds.org/medicines/674 activated charcoal 1977 Antidotes and other substances used in poisonings > Non-specific Antidotes and other substances used in poisonings > Non-specific 1 Unspecified injury, poisoning or certain other consequences of external causes 1 A07BA01 Oral > Liquid: 50 mg granules for oral suspension false false https://list.essentialmeds.org/medicines/297 adalimumab 2019 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation 3 Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type 5 L04AB04 Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL; Parenteral > General injections > SC: 10 mg per 0.2 mL mL in pre-filled syringe or pre-filled pen.; 20 mg per 0.2 mL mL in pre-filled syringe or pre-filled pen.; 20 mg per 0.4 mL mL in pre-filled syringe or pre-filled pen.; 40 mg per 0.4 mL mL in pre-filled syringe or pre-filled pen.; 40 mg per 0.8 mL mL in pre-filled syringe or pre-filled pen.; 80 mg per 0.8 mL mL in pre-filled syringe or pre-filled pen. false true https://list.essentialmeds.org/medicines/552 afatinib 2019 Targeted therapies Targeted therapies 1 Other specified malignant neoplasms of bronchus or lung 1 true false https://list.essentialmeds.org/medicines/404 albendazole 1989 Intestinal anthelminthics Intestinal anthelminthics; Cysticidal medicines; Antifilarials 3 Echinococcosis; Cysticercosis; Hookworm diseases; Trichuriasis; Ascariasis; Enterobiasis; Other specified echinococcosis; Cysticercosis of central nervous system; Lymphatic filariasis 9 P02CA03 Oral > Solid > tablet: 400 mg (chewable, scored); Oral > Solid > tablet: 400 mg (chewable, scored); 200 mg (chewable) false false https://list.essentialmeds.org/medicines/57 alcohol based hand rub 2015 Disinfectants Disinfectants 1 Denatured alcohol 1 D08AX08 Local > Topical > Solution: 80% v/v ethanol; 75% v/v isopropyl alcohol false false https://list.essentialmeds.org/medicines/173 all-trans retinoic acid 2015 Targeted therapies Targeted therapies 1 Acute myeloid leukaemia with recurrent genetic abnormalities 1 L01XF01 Oral > Solid: 10 mg capsule true false https://list.essentialmeds.org/medicines/70 allopurinol 1977 Medicines used to treat gout Medicines used to treat gout; Supportive medicines 2 Gout; Tumour lysis syndrome 2 M04AA01 Oral > Solid: 100 mg; Parenteral > General injections > IV: 500 mg (as sodium) powder for injection Oral > Solid: 100 mg; 300 mg false false https://list.essentialmeds.org/medicines/71 alprostadil (prostaglandin E1) 2009 Medicines administered to the neonate [c] Medicines administered to the neonate [c] 1 Other specified congenital anomaly of great arteries including arterial duct 1 C01EA01 Parenteral > General injections > IV: 0.5 mg per mL in alcohol false false https://list.essentialmeds.org/medicines/273 alteplase 2019 Thrombolytic medicines Thrombolytic medicines 1 Cerebral ischaemic stroke 1 B01AD02 Parenteral > General injections > IV: 10 mg in vial powder for injection; 20 mg in vial powder for injection; 50 mg in vial powder for injection false false https://list.essentialmeds.org/medicines/482 amidotrizoate 1977 Diagnostic agents > Radiocontrast media Diagnostic agents > Radiocontrast media 1 Amidotrizoate 1 V08AA01 Parenteral > General injections > unspecified: 140 to 420 mg iodine per mL in 20 mL ampoule (as sodium or meglumine salt) false false https://list.essentialmeds.org/medicines/166 amikacin 1999 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents; Access group antibiotics; Antituberculosis medicines 3 Other specified conjunctivitis; Infectious blepharitis; Acute pyelonephritis (severe); Neutropaenia (high-risk); Inflammatory or other diseases of prostate (severe); Multi-drug resistant Mycobacterium tuberculosis 6 J01GB06 Parenteral > General injections > unspecified: 50 mg per mL in 2 mL vial (as sulfate); 250 mg per mL in 2 mL vial (as sulfate) Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate); 50 mg per mL in 2 mL vial (as sulfate) Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate); Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate) cefotaxime; ceftriaxone false false https://list.essentialmeds.org/medicines/327 amiloride 1979 Diuretics Diuretics 1 Oedema; Ascites 2 C03DB01 Oral > Solid: 5 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/176 amiodarone 2009 Antiarrhythmic medicines Antiarrhythmic medicines 1 Cardiac arrhythmia 1 C01BD01 Parenteral > General injections > IV: 50 mg per mL in 3 ampoule (hydrochloride) Oral > Solid: 100 mg (hydrochloride); 200 mg (hydrochloride); 400 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/135 amitriptyline 1977 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Medicines for depressive disorders 2 Palliative care; Depressive disorders 2 N06AA09 Oral > Liquid: 25 mg per 5 mL Oral > Solid > tablet: 25 mg; 10 mg; 75 mg; Oral > Solid: 25 mg; 75 mg false false https://list.essentialmeds.org/medicines/19 amlodipine 2005 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C08CA01 Oral > Solid: 5 mg (as maleate, mesylate or besylate) false false https://list.essentialmeds.org/medicines/136 amodiaquine - sulfadoxine + pyrimethamine 2019 Antimalarial medicines > Medicines for chemoprevention Antimalarial medicines > Medicines for chemoprevention 1 Malaria 1 P01BA06, P01BD51 Oral > Solid > dispersible tablet: 76.5 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] in co-package; 153 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] in co-package; 75 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] in co-package; 150 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] in co-package false false https://list.essentialmeds.org/medicines/564 amoxicillin 1989 Access group antibiotics Access group antibiotics; Medicines for bacterial central nervous system infections 2 Acute pharyngitis; Periapical abscess without sinus; Acute sinusitis; Acute otitis media; Chronic obstructive pulmonary disease with acute exacerbation; Sepsis without septic shock; Acute malnutrition in infants, children or adolescents (uncomplicated) [children]; Acute malnutrition in infants, children or adolescents (complicated) [children]; Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Bacterial meningitis 11 J01CA04 Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate) Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate) Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate) Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid; Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate) Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate) gentamicin false false https://list.essentialmeds.org/medicines/299 amoxicillin + clavulanic acid 1997 Access group antibiotics Access group antibiotics; Antituberculosis medicines 2 Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Acute sinusitis; Other specified pneumonia (Hospital-acquired pneumonia); Chronic obstructive pulmonary disease with acute exacerbation; Neutropaenia (low-risk); Peritoneal abscess (mild-moderate); Peritonitis (mild-moderate); Infectious cystitis; Bacterial cellulitis, erysipelas or lymphangitis; Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Bacterial pneumonia (Community-acquired pneumonia - severe); Bacterial infection of joint; Acute otitis media; Other specified prophylactic measures; Osteomyelitis or osteitis; Multi-drug resistant Mycobacterium tuberculosis 16 J01CR02 Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid Oral > Solid > dispersible tablet: 250 (as trihydrate) + 62.5 (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt) false false https://list.essentialmeds.org/medicines/310 amphotericin B 1977 Antifungal medicines Antifungal medicines; Antileishmaniasis medicines 2 Candidosis; Blastomycosis; Cryptococcosis; Coccidioidomycosis; Aspergillosis; Sporotrichosis; Histoplasmosis; Visceral leishmaniasis 8 J02AA01 Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate) false false https://list.essentialmeds.org/medicines/357 ampicillin 1977 Access group antibiotics Access group antibiotics; Medicines for bacterial central nervous system infections 2 Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Acute malnutrition in infants, children or adolescents (complicated) [children]; Sepsis without septic shock; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Bacterial meningitis 8 J01CA01 Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous); Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection gentamicin false false https://list.essentialmeds.org/medicines/302 anastrozole 2015 Hormones and antihormones Hormones and antihormones; Ovulation inducers 2 Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Female infertility without specification whether primary or secondary 3 L02BG03 Oral > Solid: 1 mg tablet true false https://list.essentialmeds.org/medicines/111 anidulafungin 2021 Antifungal medicines Antifungal medicines 1 Systemic or invasive candidosis 1 false false https://list.essentialmeds.org/medicines/620 ansuvimab 2023 Medicines for Ebola virus disease Medicines for Ebola virus disease 1 Ebola virus disease 1 J06BD04 Parenteral > General injections > IV: 400 mg powder for injection false true https://list.essentialmeds.org/medicines/900 anti-D immunoglobulin 1977 Human immunoglobulins Human immunoglobulins 1 Maternal care for red cell antibodies; Rh incompatibility reaction 2 J06BB01 Parenteral > General injections > IV: 250 µg in single-dose vial Parenteral > General injections > IM: 250 µg in single-dose vial false true https://list.essentialmeds.org/medicines/460 anti-rabies immunoglobulin 1991 Human immunoglobulins Human immunoglobulins 1 Rabies 1 J06BB05 Parenteral > General injections > IM: 150 IU per mL in vial Parenteral > Locoregional injections > Other: 150 IU per mL in vial false true https://list.essentialmeds.org/medicines/462 anti-rabies virus monoclonal antibodies 2021 Immunologicals > Sera, immunoglobulins and monoclonal antibodies Immunologicals > Sera, immunoglobulins and monoclonal antibodies 1 Rabies 1 Parenteral > Locoregional injections > Intradermal: 40 IU per mL in 1.25 mL vial (human); 40 IU per mL in 2.5 mL vial (human); 100 IU per mL in 2.5 mL vial (human); 300 IU per mL in 10 mL vial (murine); 600 IU per mL in 1 mL vial (murine); 600 IU per mL in 2.5 mL vial (murine); 600 IU per mL in 5 mL vial (murine) false true https://list.essentialmeds.org/medicines/604 anti-tetanus immunoglobulin 1984 Human immunoglobulins Human immunoglobulins 1 Tetanus 1 J06BB02 Parenteral > General injections > IM: 500 IU in vial false true https://list.essentialmeds.org/medicines/464 antivenom immunoglobulin 2007 Immunologicals > Sera, immunoglobulins and monoclonal antibodies Immunologicals > Sera, immunoglobulins and monoclonal antibodies 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 Parenteral > General injections > IV: false true https://list.essentialmeds.org/medicines/508 apixaban 2019 Medicines affecting coagulation Medicines affecting coagulation 1 Other specified atrial fibrillation; Venous thromboembolism 2 false false https://list.essentialmeds.org/medicines/478 aprepitant 2019 Antiemetic medicines Antiemetic medicines 1 Nausea or vomiting 1 A04AD12 Oral > Liquid: 125 mg powder for oral suspension (in sachet) Oral > Solid > capsule: 80 mg; 125 mg; 165 mg false false https://list.essentialmeds.org/medicines/536 aripiprazole 2023 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 Parenteral > General injections > IM: 300 mg powder and solvent for suspension; 400 mg powder and solvent for suspension false false https://list.essentialmeds.org/medicines/921 arpraziquantel 2025 Antischistosomals and other antitrematode medicines Antischistosomals and other antitrematode medicines 1 Schistosomiasis 1 Oral > Solid > dispersible tablet: 150 mg false false https://list.essentialmeds.org/medicines/948 arsenic trioxide 2019 Cytotoxic medicines Cytotoxic medicines 1 Acute myeloid leukaemia with recurrent genetic abnormalities 1 L01XX27 Parenteral > General injections > IV: 1 mg per mL concentrate for solution for infusion; 2 mg per mL concentrate for solution for infusion false false https://list.essentialmeds.org/medicines/554 artemether 1997 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BE02 Parenteral > General injections > IM: 20 mg per mL in 1 mL ampoule (oily injection); 40 mg per mL in 1 mL ampoule (oily injection) false false https://list.essentialmeds.org/medicines/372 artemether + lumefantrine 2002 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BF01 Oral > Solid > dispersible tablet: 20 mg + 120 mg Oral > Solid > tablet: 20 mg + 120 mg false false https://list.essentialmeds.org/medicines/373 artesunate 1999 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BE03 Parenteral > General injections > IV: 60 mg in vial powder for injection; 30 mg in vial powder for injection; 120 mg in vial powder for injection Local > Rectal > Other: 100 mg capsules false false https://list.essentialmeds.org/medicines/374 artesunate + amodiaquine 2011 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BF03 Oral > Solid > tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100 mg + 270 mg Oral > Solid > tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100 mg + 270 mg tablet false false https://list.essentialmeds.org/medicines/375 artesunate + mefloquine 2013 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BF02 Oral > Solid > tablet: 25 mg + 50 mg (as hydrochloride); 100 mg + 200 mg (as hydrochloride) false false https://list.essentialmeds.org/medicines/376 artesunate + pyronaridine 2017 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BF06 Oral > Solid > tablet: 60 mg + 180 mg (tetraphosphate) Oral > Solid > granules: 20 mg + 60 mg (tetraphosphate) false false https://list.essentialmeds.org/medicines/377 artesunate - sulfadoxine + pyrimethamine 2025 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BF09 Oral > Solid > tablet: 50 mg [3] + 500 mg + 25 mg [1] in copackage (scored) false false https://list.essentialmeds.org/medicines/978 ascorbic acid 1977 Vitamins and minerals Vitamins and minerals 1 Scurvy 1 A11GA01 Oral > Solid: 50 mg false false https://list.essentialmeds.org/medicines/259 asparaginase 1993 Cytotoxic medicines Cytotoxic medicines 1 Lymphoid leukaemia, not elsewhere classified 1 L01XX02 Parenteral > General injections > unspecified: 10000 IU in vial powder for injection Powder for injection: 10 000 IU in vial. false true https://list.essentialmeds.org/medicines/72 atazanavir + ritonavir 2017 Antiretrovirals > Protease inhibitors Antiretrovirals > Protease inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR23 Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable) false false https://list.essentialmeds.org/medicines/283 atenolol 1991 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 Oral > Solid: 50 mg; 100 mg false false https://list.essentialmeds.org/medicines/496 atezolizumab 2025 Immunomodulators Immunomodulators 1 Other specified malignant neoplasms of bronchus or lung 1 Parenteral > General injections > IV: 840 mg per 14 mL in vial concentrate for solution for infusion; 1200 mg per 20 mL in vial concentrate for solution for infusion Parenteral > General injections > IV: 1.2 g per 20 mL concentrate solution for infusion true true https://list.essentialmeds.org/medicines/570 atoltivimab + maftivimab + odesivimab 2023 Medicines for Ebola virus disease Medicines for Ebola virus disease 1 Ebola virus disease 1 Parenteral > General injections > IV: 241.7 mg + 241.7 mg + 241.7 mg in 14.5 mL vial false true https://list.essentialmeds.org/medicines/901 atorvastatin 2021 Lipid-lowering agents Lipid-lowering agents 1 Mixed hyperlipidaemia; Coronary atherosclerosis 2 false false https://list.essentialmeds.org/medicines/529 atorvastatin + perindopril + amlodipine 2023 Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease 1 Atherosclerotic chronic arterial occlusive disease; Chronic ischaemic heart disease; Cerebral ischaemic stroke 3 C10BX11 Oral > Solid > tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg + 5 mg + 5 mg; 40 mg + 10 mg + 10 mg false false https://list.essentialmeds.org/medicines/912 atracurium 2011 Muscle relaxants (peripherally-acting) and cholinesterase inhibitors Muscle relaxants (peripherally-acting) and cholinesterase inhibitors 1 Muscle relaxants 1 M03AC04 Parenteral > General injections > IV: 10 mg per mL (besylate) false false https://list.essentialmeds.org/medicines/222 atropine 1977 Diagnostic agents > Ophthalmic medicines Diagnostic agents > Ophthalmic medicines; Ophthalmological preparations > Mydriatics; Antidotes and other substances used in poisonings > Specific; Preoperative medication and sedation for short-term procedures 4 Cycloplegic drug; Anterior uveitis; Exposure to or harmful effects of undetermined intent of pesticides; Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics 4 S01FA01, A03BA01 Local > Ophthalmological > Solution (eye drops): 0.1% (sulfate); 0.5% (sulfate); 1% (sulfate); Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule or vial (sulfate); Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule or vial (sulfate); 400 µg per mL in 1 mL ampoule or vial (sulfate) false false https://list.essentialmeds.org/medicines/10 azathioprine 1979 Disease-modifying anti-rheumatic drugs (DMARDs) Disease-modifying anti-rheumatic drugs (DMARDs); Immunomodulators for non-malignant disease 2 Rheumatoid arthritis, serology unspecified; Psoriatic arthritis; Failure or rejection of transplanted organs or tissues 3 L04AX01 Oral > Solid > tablet: 50 mg (scored); Oral > Solid > tablet: 50 mg (scored) Parenteral > General injections > IV: 50 mg in vial powder for injection (as sodium salt); 100 mg in vial powder for injection (as sodium salt) Oral > Liquid: 10 mg per mL Oral > Solid > tablet: 25 mg; 50 mg (scored) false false https://list.essentialmeds.org/medicines/68 azithromycin 2003 Watch group antibiotics Watch group antibiotics; Ophthalmological preparations > Anti-infective agents 2 Cholera; Cholera [children]; Paratyphoid fever; Chlamydia trachomatis; Typhoid fever; Yaws; Trachoma; Gonococcal infection; Infectious gastroenteritis or colitis without specification of infectious agent 9 J01FA10, S01AA26 Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous); Local > Ophthalmological > Solution (eye drops): 1.5% eye drops ceftriaxone; cefixime false false https://list.essentialmeds.org/medicines/227 baclofen 2025 Medicines for cerebral palsy Medicines for cerebral palsy 1 Spastic cerebral palsy 1 M03BX01 Oral > Liquid: 10 mg per 5 mL Parenteral > Locoregional injections > Intrathecal: 500 µg per mL in ampoule Oral > Solid > tablet: 10 mg false false https://list.essentialmeds.org/medicines/971 barium sulfate 1977 Diagnostic agents > Radiocontrast media Diagnostic agents > Radiocontrast media 1 Barium sulfate with suspending agents 1 V08BA01 Oral > Liquid: Aqueous suspension false false https://list.essentialmeds.org/medicines/167 beclometasone 1979 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 Respiratory > Inhalation > aerosol: 50 µg per dose (dipropionate); 250 µg per dose (dipropionatae) false false https://list.essentialmeds.org/medicines/250 beclometasone + formoterol 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/669 bedaquiline 2015 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J04AK05 Oral > Solid > tablet: 100 mg tablet; 20 mg tablet false false https://list.essentialmeds.org/medicines/279 bendamustine 2015 Cytotoxic medicines Cytotoxic medicines 1 Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Follicular lymphoma 2 L01AA09 Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL true false https://list.essentialmeds.org/medicines/73 benzathine benzylpenicillin 1977 Access group antibiotics Access group antibiotics 1 Congenital syphilis [children]; Syphilis 2 J01CE08 Parenteral > General injections > IM: 1.2 million IU in vial (≈ 900 mg) powder for injection; 2.4 million IU in vial (≈ 1.8 g) powder for injection false false https://list.essentialmeds.org/medicines/311 benznidazole 1987 American trypanosomiasis American trypanosomiasis 1 Chagas disease 1 P01CA02 Oral > Solid > tablet: 100 mg (scored); 50 mg (scored); 12.5 mg false false https://list.essentialmeds.org/medicines/391 benzoyl peroxide 1989 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Acne 1 D10AE01 Local > Topical > Cream: 5% Local > Topical > Lotion: 5% false false https://list.essentialmeds.org/medicines/157 benzyl benzoate 1977 Dermatological medicines > Scabicides and pediculicides Dermatological medicines > Scabicides and pediculicides 1 Pediculosis corporis; Pediculosis capitis; Pthiriasis; Scabies 4 P03AX01 Local > Topical > Lotion: 25% false false https://list.essentialmeds.org/medicines/162 benzylpenicillin 1977 Access group antibiotics Access group antibiotics; Medicines for bacterial central nervous system infections 2 Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Acute malnutrition in infants, children or adolescents (complicated) [children]; Sepsis without septic shock; Congenital syphilis [children]; Syphilis; Bacterial meningitis 6 J01CE01 Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt) Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt); Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt) gentamicin false false https://list.essentialmeds.org/medicines/303 beractant 2009 Medicines administered to the neonate [c] Medicines administered to the neonate [c] 1 Respiratory distress syndrome of newborn 1 R07AA02 Respiratory > Suspension: 25 mg per mL for intratracheal instillation false true https://list.essentialmeds.org/medicines/274 betamethasone 1977 Dermatological medicines > Anti-inflammatory and antipruritic medicines Dermatological medicines > Anti-inflammatory and antipruritic medicines 1 Dermatitis or eczema; Pruritus due to skin disorder; Psoriasis of unspecified type; Lichen planus 4 D07AC01 Local > Topical > Cream: 0.1% (as valerate) Local > Topical > Ointment: 0.1% (as valerate) false false https://list.essentialmeds.org/medicines/155 bevacizumab 2013 Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations 1 Age-related macular degeneration 1 S01LA08 Parenteral > Locoregional injections > Intravitreal: 25 mg per mL false true https://list.essentialmeds.org/medicines/238 bicalutamide 2015 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of prostate 1 L02BB03 Oral > Solid: 50 mg true false https://list.essentialmeds.org/medicines/112 biperiden 1982 Medicines for parkinsonism Medicines for parkinsonism 1 Parkinson disease 1 N04AA02 Parenteral > General injections > IV: 5 mg per mL in 1 mL ampoule (lactate) Oral > Solid: 2 mg tablet (hydrochloride) false false https://list.essentialmeds.org/medicines/116 bisacodyl 2021 Laxatives Laxatives 1 Constipation 1 false false https://list.essentialmeds.org/medicines/652 bisoprolol 2011 Antianginal medicines Antianginal medicines; Antihypertensive medicines; Antiarrhythmic medicines; Medicines used in heart failure 4 Angina pectoris; Essential hypertension; Cardiac arrhythmia; Heart failure 4 C07AB07 Oral > Solid: 1.25 mg; 5 mg false false https://list.essentialmeds.org/medicines/130 bleomycin 1979 Cytotoxic medicines Cytotoxic medicines 1 Kaposi sarcoma of unspecified primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Hodgkin lymphoma 4 L01DC01 Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate) true false https://list.essentialmeds.org/medicines/74 blinatumomab 2025 Immunomodulators Immunomodulators 1 B lymphoblastic leukaemia or lymphoma, not elsewhere classified 1 L01FX07 Parenteral > General injections > IV: 35 µg in vial; 38.5 µg in vial false false https://list.essentialmeds.org/medicines/949 bortezomib 2019 Targeted therapies Targeted therapies 1 Plasma cell myeloma 1 L01XG01 Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection true false https://list.essentialmeds.org/medicines/407 bromocriptine Medicines for disorders of the pituitary hormone system Medicines for disorders of the pituitary hormone system 1 Other specified benign neoplasm of endocrine glands 1 false false https://list.essentialmeds.org/medicines/592 budesonide 2007 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease; Ear, nose and throat medicines [c] 2 Asthma; Allergic rhinitis 2 R03BA02, R01AD05 Respiratory > Inhalation > powder: 100 µg per actuation in dry powder inhaler; 200 µg per actuation in dry powder inhaler Respiratory > Inhalation > suspension: 100 µg per actuation in pressurized metered dose inhaler; 200 µg per actuation in pressurized metered dose inhaler; Local > Nasal > Spray: 32 µg per actuation; 64 µg per actuation false false https://list.essentialmeds.org/medicines/251 budesonide + formoterol 2017 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 R03AK07 Respiratory > Inhalation > powder: 100 µg + 6 µg per dose actuation in dry powder inhaler; 200 µg + 6 µg per dose actuation in dry powder inhaler false false https://list.essentialmeds.org/medicines/252 budesonide + salmeterol 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/668 bumetanide 2023 Diuretics Diuretics; Medicines used in heart failure 2 Anuria or oliguria; Oedema; Heart failure 3 false false https://list.essentialmeds.org/medicines/648 bupivacaine 1977 Local anaesthetics Local anaesthetics 1 Local anaesthetics 1 N01BB01 Parenteral > Locoregional injections > Spinal anaesthesia: 0.5% in 4 mL ampoule (hydrochloride) + 8% glucose solution Parenteral > General injections > unspecified: 0.25% (hydrochloride); 0.5% (hydrochloride) false false https://list.essentialmeds.org/medicines/7 buprenorphine 2005 Medicines for opioid use disorders Medicines for opioid use disorders 1 Opioid dependence 1 false false https://list.essentialmeds.org/medicines/644 bupropion 2021 Medicines for nicotine use disorders Medicines for nicotine use disorders 1 Nicotine dependence 1 N06AX12 Oral > Solid: 150 mg sustained-release (hydrochloride) false false https://list.essentialmeds.org/medicines/606 cabergoline 2023 Medicines for disorders of the pituitary hormone system Medicines for disorders of the pituitary hormone system 1 Other specified benign neoplasm of endocrine glands 1 G02CB03 Oral > Solid > tablet: 0.5 mg; 1 mg false false https://list.essentialmeds.org/medicines/593 caffeine citrate 2007 Medicines administered to the neonate [c] Medicines administered to the neonate [c] 1 Apnoea of newborn 1 N06BC01 Parenteral > General injections > IV: 20 mg per mL (equivalent to 10 mg caffeine base per mL) Oral > Liquid: 20 mg per mL (equivalent to 10 mg caffeine base per mL) false false https://list.essentialmeds.org/medicines/426 calamine 1982 Dermatological medicines > Anti-inflammatory and antipruritic medicines Dermatological medicines > Anti-inflammatory and antipruritic medicines 1 Pruritus 1 D02AB Local > Topical > Lotion: false false https://list.essentialmeds.org/medicines/156 calcipotriol 2021 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Psoriasis of unspecified type 1 D05AX02 Local > Topical > Cream: 50 µg per mL (0.005%) Local > Topical > Lotion: 50 µg per mL (0.005%) Local > Topical > Ointment: 50 µg per mL (0.005%) false false https://list.essentialmeds.org/medicines/609 calcitriol 2021 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Psoriasis of unspecified type 1 false false https://list.essentialmeds.org/medicines/608 calcium 2013 Vitamins and minerals Vitamins and minerals 1 Calcium deficiency 1 A12AA20 Oral > Solid: 500 mg (elemental calcium) false false https://list.essentialmeds.org/medicines/260 calcium folinate (leucovorin calcium) 1979 Cytotoxic medicines Cytotoxic medicines 1 Burkitt lymphoma including Burkitt leukaemia; Osteosarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon; Malignant trophoblastic neoplasms of placenta 6 V03AF03 Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule; 7.5 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule Oral > Solid > tablet: 15 mg; 5 mg; 25 mg Oral > Solid: 15 mg tablet Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule true false https://list.essentialmeds.org/medicines/75 calcium gluconate 1977 Vitamins and minerals Vitamins and minerals; Antidotes and other substances used in poisonings > Specific 2 Tetany due to acute calcium deficiency; Hypermagnesaemia 2 A12AA03 Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule; Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule or vial (10%) false false https://list.essentialmeds.org/medicines/37 canagliflozin 2021 Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 false false https://list.essentialmeds.org/medicines/612 capecitabine 2015 Cytotoxic medicines Cytotoxic medicines 1 Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon; Other specified malignant neoplasms of breast 4 L01BC06 Oral > Solid > tablet: 150 mg; 500 mg true false https://list.essentialmeds.org/medicines/76 carbachol 2021 Ophthalmological preparations > Miotics and antiglaucoma medicines Ophthalmological preparations > Miotics and antiglaucoma medicines 1 Acute angle closure with pupillary block; Ocular hypertension; Primary open-angle glaucoma 3 false false https://list.essentialmeds.org/medicines/657 carbamazepine 1977 Antiseizure medicines Antiseizure medicines; Medicines for bipolar disorders 2 Epilepsy or seizures; Bipolar or related disorders 2 N03AF01 Oral > Liquid: 100 mg per 5 mL Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored); Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 400 mg false false https://list.essentialmeds.org/medicines/49 carbetocin 2019 Uterotonics Uterotonics 1 Postpartum haemorrhage 1 H01BB03 Parenteral > General injections > IV: 100 µg per mL (heat stable) false false https://list.essentialmeds.org/medicines/425 carbimazole 2025 Thyroid hormones and antithyroid medicines Thyroid hormones and antithyroid medicines 1 Thyrotoxicosis 1 false false https://list.essentialmeds.org/medicines/507 carboplatin 2009 Cytotoxic medicines Cytotoxic medicines 1 Other specified gliomas of brain; Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx; Malignant neoplasms of cervix uteri; Malignant neoplasms of hypopharynx; Malignant neoplasms of nasopharynx; Malignant neoplasms of oropharynx; Osteosarcoma of bone or articular cartilage of unspecified sites; Other specified malignant neoplasms of the ovary; Germ cell tumour of testis; Other specified carcinomas of ovary; Other specified malignant neoplasms of bronchus or lung; Malignant neoplasms of breast; Retinoblastoma; Malignant neoplasms of kidney, except renal pelvis 14 L01XA02 Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL true false https://list.essentialmeds.org/medicines/77 carvedilol 2011 Antianginal medicines Antianginal medicines; Antihypertensive medicines; Antiarrhythmic medicines; Medicines used in heart failure 4 Angina pectoris; Essential hypertension; Cardiac arrhythmia; Heart failure 4 false false https://list.essentialmeds.org/medicines/498 caspofungin 2021 Antifungal medicines Antifungal medicines 1 Systemic or invasive candidosis 1 false false https://list.essentialmeds.org/medicines/619 cefalexin 2009 Access group antibiotics Access group antibiotics 1 Bacterial cellulitis, erysipelas or lymphangitis; Chronic obstructive pulmonary disease with acute exacerbation; Acute pharyngitis 3 J01DB01 Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid Oral > Solid: 250 mg (as monohydrate); 500 mg (as monohydrate) Oral > Solid > dispersible tablet: 125 mg; 250 mg Oral > Solid: 250 mg (as monohydrate) false false https://list.essentialmeds.org/medicines/304 cefazolin 2007 Access group antibiotics Access group antibiotics 1 Other specified prophylactic measures; Bacterial infection of joint; Osteomyelitis or osteitis 3 J01DB04 Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection metronidazole false false https://list.essentialmeds.org/medicines/305 cefiderocol 2021 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli 4 J01DI04 Parenteral > General injections > IV: 1 g in vial (as sulfate tosylate) powder for injection false false https://list.essentialmeds.org/medicines/611 cefixime 2005 Watch group antibiotics Watch group antibiotics 1 Infectious gastroenteritis or colitis without specification of infectious agent; Gonococcal infection 2 J01DD08 Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate) azithromycin false false https://list.essentialmeds.org/medicines/307 cefotaxime 2009 Watch group antibiotics Watch group antibiotics; Medicines for bacterial central nervous system infections 2 Acute pyelonephritis (severe); Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Bacterial pneumonia (Community-acquired pneumonia - severe); Other specified pneumonia (Hospital-acquired pneumonia); Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Inflammatory or other diseases of prostate (severe); Bacterial meningitis; Acute pyelonephritis (mild to moderate); Sepsis without septic shock; Bacterial infection of joint; Inflammatory or other diseases of prostate (mild to moderate); Osteomyelitis or osteitis 15 J01DD01 Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) metronidazole; amikacin false false https://list.essentialmeds.org/medicines/312 ceftazidime 1995 Watch group antibiotics Watch group antibiotics 1 Endophthalmitis; Pseudomonas aeruginosa resistant to other antibiotic 2 J01DD02 Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection false false https://list.essentialmeds.org/medicines/328 ceftazidime + avibactam 2019 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli 4 J01DD52 Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection false false https://list.essentialmeds.org/medicines/395 ceftolozane + tazobactam 2023 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem-resistant Pseudomonas aeruginosa 1 J01DI54 Parenteral > General injections > IV: 1 g + 0.5 g powder for injection false false https://list.essentialmeds.org/medicines/398 ceftriaxone 1995 Watch group antibiotics Watch group antibiotics; Medicines for bacterial central nervous system infections 2 Other specified pneumonia (Hospital-acquired pneumonia); Acute pyelonephritis (severe); Paratyphoid fever; Typhoid fever; Endophthalmitis; Bacterial pneumonia (Community-acquired pneumonia - severe); Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Necrotising fasciitis; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Inflammatory or other diseases of prostate (severe); Gonococcal infection; Bacterial meningitis; Acute pyelonephritis (mild to moderate); Bacterial infection of joint; Sepsis without septic shock; Infectious gastroenteritis or colitis without specification of infectious agent; Inflammatory or other diseases of prostate (mild to moderate); Osteomyelitis or osteitis 21 J01DD04 Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt) Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) metronidazole; amikacin; azithromycin false false https://list.essentialmeds.org/medicines/314 cefuroxime 2019 Watch group antibiotics Watch group antibiotics 1 Other specified prophylactic measures 1 J01DC02 Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection false false https://list.essentialmeds.org/medicines/401 cemiplimab 2025 Immunomodulators Immunomodulators 1 Other specified malignant neoplasms of bronchus or lung 1 L01FF06 Parenteral > General injections > IV: 50 mg per mL in 7 mL vial concentrate for solution for infusion true true https://list.essentialmeds.org/medicines/937 certolizumab pegol 2023 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation 3 Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type 5 false true https://list.essentialmeds.org/medicines/550 cetirizine 2025 Antiallergics and medicines used in anaphylaxis Antiallergics and medicines used in anaphylaxis 1 Allergic or hypersensitivity conditions of unspecified type 1 false false https://list.essentialmeds.org/medicines/633 chlorambucil 1979 Cytotoxic medicines Cytotoxic medicines 1 Chronic lymphocytic leukaemia or small lymphocytic lymphoma 1 L01AA02 Oral > Solid: 2 mg tablet true false https://list.essentialmeds.org/medicines/78 chloramphenicol 1977 Access group antibiotics Access group antibiotics; Medicines for bacterial central nervous system infections 2 Bacterial meningitis 1 J01BA01 Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate) Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection Oral > Liquid: 150 mg per 5 mL (as palmitate) Oral > Solid: 250 mg capsule; Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate) Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection false false https://list.essentialmeds.org/medicines/332 chlorhexidine 1979 Medicines administered to the neonate [c] Medicines administered to the neonate [c]; Antiseptics 2 Omphalitis of newborn; Chlorhexidine 2 D08AC02 Local > Topical > Solution: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine) Local > Topical > Gel: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine); Local > Topical > Solution: 5% (digluconate) for dilution false false https://list.essentialmeds.org/medicines/170 chlorine base compound 1997 Disinfectants Disinfectants 1 Disinfectant, not elsewhere classified 1 V07AV Local > Topical > Powder: 0.1% available chlorine for solution Local > Topical > Liquid: 0.1% available chlorine for solution Local > Topical > Solid: 0.1% available chlorine for solution false false https://list.essentialmeds.org/medicines/174 chloroquine 1977 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment; Disease-modifying anti-rheumatic drugs (DMARDs); Antimalarial medicines > Medicines for chemoprophylaxis in travellers 3 Malaria due to Plasmodium vivax; Rheumatoid arthritis 2 P01BA01 Parenteral > General injections > IV: 40 mg per mL in 5 mL ampoule (as hydrochloride, phosphate or sulfate) Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate) Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate) Oral > Liquid: 50 mg per 5 mL (base) Oral > Solid > tablet: 150 mg (base); Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate); Oral > Liquid: 50 mg per 5 mL (base) Oral > Solid > tablet: 150 mg (base) false false https://list.essentialmeds.org/medicines/275 chlorothiazide 2021 Antihypertensive medicines Antihypertensive medicines; Medicines used in heart failure 2 Essential hypertension; Heart failure 2 false false https://list.essentialmeds.org/medicines/645 chloroxylenol 1997 Disinfectants Disinfectants 1 Phenol disinfectant, not elsewhere classified 1 D08AE05 Local > Topical > Solution: 4.8% false false https://list.essentialmeds.org/medicines/175 chlorpromazine 1977 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 Oral > Liquid: 25 mg per 5 mL (hydrochloride) Oral > Solid: 100 mg (hydrochloride) Oral > Solid: 100 mg (hydrochloride); 10 mg (hydrochloride); 25 mg (hydrochloride); 50 mg (hydrochloride) Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (hydrochloride) false false https://list.essentialmeds.org/medicines/244 chlortalidone 2021 Antihypertensive medicines Antihypertensive medicines; Medicines used in heart failure 2 Essential hypertension; Heart failure 2 false false https://list.essentialmeds.org/medicines/646 chlortetracycline 2021 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Other specified conjunctivitis; Infectious keratitis; Infectious blepharitis; Trachoma 4 false false https://list.essentialmeds.org/medicines/655 cholera vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against cholera alone 1 J07AE01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/435 ciclesonide 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/664 ciclosporin 1991 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease 1 Failure or rejection of transplanted organs or tissues 1 L04AD01 Parenteral > General injections > IV: 50 mg per mL in 1 mL ampoule concentrate for injection Oral > Liquid: 100 mg per mL Oral > Solid > capsule: 25 mg false false https://list.essentialmeds.org/medicines/69 ciprofloxacin 1991 Ear, nose and throat medicines [c] Ear, nose and throat medicines [c]; Watch group antibiotics 2 Infectious diseases of external ear; Acute pyelonephritis (mild to moderate); Paratyphoid fever; Typhoid fever; Infectious gastroenteritis or colitis without specification of infectious agent; Neutropaenia (low-risk); Inflammatory or other diseases of prostate (mild to moderate); Cholera; Cholera [children]; Peritoneal abscess (mild-moderate); Peritonitis (mild-moderate) 11 S02AA15, J01MA02 Local > Otological > drops: 0.3% (as hydrochloride); Parenteral > General injections > IV: 2 mg per mL (as hyclate) Oral > Liquid: 250 mg per 5 mL (anhydrous) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride) Oral > Solid: 250 mg (as hydrochloride) metronidazole false false https://list.essentialmeds.org/medicines/271 cisplatin 1984 Cytotoxic medicines Cytotoxic medicines 1 Other specified gliomas of brain; Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx; Malignant neoplasms of cervix uteri; Malignant neoplasms of hypopharynx; Malignant neoplasms of oropharynx; Malignant neoplasms of nasopharynx; Germ cell tumour of testis; Osteosarcoma of bone or articular cartilage of unspecified sites; Other specified malignant neoplasms of the ovary; Other specified malignant neoplasms of bronchus or lung 10 L01XA01 Parenteral > General injections > IV: 10 mg per 10 mL; 20 mg per 20 mL; 50 mg per 50 mL; 100 mg per 100 mL Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection true false https://list.essentialmeds.org/medicines/79 citalopram 2023 Medicines for anxiety disorders Medicines for anxiety disorders 1 Generalised anxiety disorder 1 false false https://list.essentialmeds.org/medicines/659 cladribine 2023 Medicines for multiple sclerosis Medicines for multiple sclerosis 1 Multiple sclerosis 1 L04AA40 Oral > Solid > tablet: 10 mg false false https://list.essentialmeds.org/medicines/903 clarithromycin 2011 Watch group antibiotics Watch group antibiotics 1 Bacterial pneumonia (Community-acquired pneumonia - severe); Acute pharyngitis; Helicobacter pylori associated gastric ulcer 3 J01FA09 Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid Parenteral > General injections > unspecified: 500 mg in vial powder for injection Oral > Solid > dosage form: 500 mg; 250 mg Oral > Solid > dosage form: 500 mg cefotaxime; ceftriaxone; amoxicillin + clavulanic acid false false https://list.essentialmeds.org/medicines/317 clindamycin 1991 Access group antibiotics Access group antibiotics 1 Necrotising fasciitis; Bacterial infection of joint; Osteomyelitis or osteitis 3 J01FF01 Parenteral > General injections > IV: 150 mg per mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate) Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride) Oral > Solid: 150 mg (as hydrochloride) Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride) Oral > Solid: 150 mg (as hydrochloride) capsule Parenteral > General injections > unspecified: 150 mg per mL (as phosphate) injection false false https://list.essentialmeds.org/medicines/309 clofazimine 1977 Antituberculosis medicines Antituberculosis medicines; Antileprosy medicines 2 Multi-drug resistant Mycobacterium tuberculosis; Leprosy 2 J04BA01 Oral > Solid > dosage form: 100 mg; 50 mg false false https://list.essentialmeds.org/medicines/292 clomifene 1979 Ovulation inducers Ovulation inducers 1 Female infertility without specification whether primary or secondary 1 G03GB02 Oral > Solid: 50 mg (citrate) false false https://list.essentialmeds.org/medicines/198 clomipramine 1993 Medicines for obsessive compulsive disorders Medicines for obsessive compulsive disorders 1 Obsessive-compulsive disorder 1 N06AA04 Oral > Solid: 10 mg (hydrochloride); 25 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/249 clopidogrel 2015 Anti-platelet medicines Anti-platelet medicines 1 Acute ischaemic heart disease; Presence of coronary angioplasty implant or graft 2 B01AC04 Oral > Solid: 75 mg; 300 mg false false https://list.essentialmeds.org/medicines/146 clotrimazole 2005 Antifungal medicines Antifungal medicines 1 Vulvovaginal candidosis 1 G01AF02 Local > Topical > Other: 1% vaginal cream; 10% vaginal cream; 100 mg vaginal tablet; 500 mg vaginal tablet false false https://list.essentialmeds.org/medicines/358 cloxacillin 1977 Access group antibiotics Access group antibiotics 1 Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock 4 J01CF02 Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid; 250 mg per 5 mL (as sodium salt) powder for oral liquid Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 250 mg in vial (as sodium salt) powder for injection Oral > Solid > capsule: 500 mg (as sodium salt); 1 g (as sodium salt); 250 mg (as sodium salt) Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection false false https://list.essentialmeds.org/medicines/306 clozapine 2013 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 N05AH02 Oral > Solid: 25 mg; 50 mg; 100 mg; 200 mg false false https://list.essentialmeds.org/medicines/247 coagulation factor IX complex 2025 Coagulation factors Coagulation factors 1 Coagulation defects, purpura or other haemorrhagic or related conditions; Haemophilia B 2 false true https://list.essentialmeds.org/medicines/940 coagulation factor IX, plasma-derived 1979 Coagulation factors Coagulation factors 1 Coagulation defects, purpura or other haemorrhagic or related conditions; Haemophilia B 2 B02BD01, B02BD04 Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection false true https://list.essentialmeds.org/medicines/468 coagulation factor IX, recombinant 2025 Coagulation factors Coagulation factors 1 Haemophilia B 1 B02BD04 Parenteral > General injections > IV: 250 IU per mL in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection false false https://list.essentialmeds.org/medicines/951 coagulation factor VIII, plasma-derived 1979 Coagulation factors Coagulation factors 1 Haemophilia A 1 B02BD02 Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection false true https://list.essentialmeds.org/medicines/466 coagulation factor VIII, recombinant 2025 Coagulation factors Coagulation factors 1 Haemophilia A 1 B02BD02 Parenteral > General injections > IV: 250 IU in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection false false https://list.essentialmeds.org/medicines/950 coal tar 1977 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Psoriasis of unspecified type 1 D05AA Local > Topical > Solution: 5% false false https://list.essentialmeds.org/medicines/158 codeine 1977 Opioid analgesics Opioid analgesics 1 Pain 1 Oral > Solid: 30 mg tablet (codeine phosphate) false false https://list.essentialmeds.org/medicines/16 colecalciferol 2007 Vitamins and minerals Vitamins and minerals 1 Calcium deficiency; Vitamin D deficiency 2 A11CC05 Oral > Liquid: 400 IU per mL Oral > Solid: 400 IU; 1000 IU false false https://list.essentialmeds.org/medicines/261 colistin (injection) 2017 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem resistant Acinetobacter baumannii; Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli 5 J01XB01 Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) (equivalent to 34 mg colistin base activity) false false https://list.essentialmeds.org/medicines/348 compound sodium lactate solution 1977 Solutions correcting water, electrolyte and acid-base disturbances > Parenteral Solutions correcting water, electrolyte and acid-base disturbances > Parenteral 1 Hypovolaemic shock; Other specified disorders of fluid, electrolyte or acid-base balance 2 B05BB01 Parenteral > General injections > IV: injectable solution false false https://list.essentialmeds.org/medicines/544 condoms 1987 Barrier methods Barrier methods 1 Contact with health services for contraceptive management 1 - false false https://list.essentialmeds.org/medicines/422 copper-containing intrauterine device 1987 Intrauterine devices Intrauterine devices 1 Contact with health services for insertion of contraceptive device 1 G02BA02 - false false https://list.essentialmeds.org/medicines/421 cryoprecipitate (native) 2023 Blood and blood components Blood and blood components 1 Coagulation defects, purpura or other haemorrhagic or related conditions; Obstetric haemorrhage 2 false true https://list.essentialmeds.org/medicines/914 cryoprecipitate (pathogen-reduced) 2023 Blood and blood components Blood and blood components 1 Coagulation defects, purpura or other haemorrhagic or related conditions; Obstetric haemorrhage 2 B05AA02 Injection: frozen liquid in bag or lyophilized powder in vial containing: > 50 IU Factor VIII > 100 IU vWF > 140 mg clottable fibrinogen per unit false true https://list.essentialmeds.org/medicines/915 cyclizine 2009 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care 1 Palliative care 1 R06AE03 Parenteral > General injections > unspecified: 50 mg per mL (lactate) Oral > Solid > tablet: 50 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/20 cyclopentolate 2021 Diagnostic agents > Ophthalmic medicines Diagnostic agents > Ophthalmic medicines; Ophthalmological preparations > Mydriatics 2 Cycloplegic drug; Anterior uveitis 2 false false https://list.essentialmeds.org/medicines/651 cyclophosphamide 1977 Cytotoxic medicines Cytotoxic medicines 1 Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Other specified gliomas of brain; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Rhabdomyosarcoma primary site; Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Hodgkin lymphoma; Malignant trophoblastic neoplasms of placenta; Follicular lymphoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis 16 L01AA01 Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection Oral > Solid > dosage form: 25 mg; 50 mg Oral > Solid: 25 mg tablet Parenteral > General injections > unspecified: 500 mg in vial powder for injection true false https://list.essentialmeds.org/medicines/80 cycloserine 1999 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J04AB01 Oral > Solid > dosage form: 250 mg; 125 mg false false https://list.essentialmeds.org/medicines/350 cytarabine 1979 Cytotoxic medicines Cytotoxic medicines 1 Acute myeloid leukaemia with recurrent genetic abnormalities; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Myeloid leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis 7 L01BC01 Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per mL in vial Parenteral > General injections > unspecified: 100 mg in vial powder for injection true false https://list.essentialmeds.org/medicines/81 cytisine (cytisinicline) 2025 Medicines for nicotine use disorders Medicines for nicotine use disorders 1 Nicotine dependence 1 N07BA04 Oral > Solid > tablet: 1.5 mg false false https://list.essentialmeds.org/medicines/952 dabigatran 2019 Medicines affecting coagulation Medicines affecting coagulation 1 Other specified atrial fibrillation; Venous thromboembolism 2 B01AE07 Oral > Solid: 110 mg; 150 mg false false https://list.essentialmeds.org/medicines/479 dacarbazine 1989 Cytotoxic medicines Cytotoxic medicines 1 Hodgkin lymphoma 1 L01AX04 Parenteral > General injections > IV: 100 mg in vial powder for injection; 200 mg in vial powder for injection true false https://list.essentialmeds.org/medicines/82 daclatasvir 2015 Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP07 Oral > Solid > tablet: 30 mg (as dihydrochloride); 60 mg (as dihydrochloride) false false https://list.essentialmeds.org/medicines/295 daclatasvir + sofosbuvir 2021 Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP07, J05AP08 Oral > Solid > tablet: 60 mg (as dihydrochloride) + 400 mg false false https://list.essentialmeds.org/medicines/626 dactinomycin 1984 Cytotoxic medicines Cytotoxic medicines 1 Rhabdomyosarcoma primary site; Malignant trophoblastic neoplasms of placenta; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis 4 L01DA01 Parenteral > General injections > IV: 500 µg in vial powder for injection true false https://list.essentialmeds.org/medicines/83 dalteparin 2015 Medicines affecting coagulation Medicines affecting coagulation 1 Acute ischaemic heart disease; Venous thromboembolism 2 false true https://list.essentialmeds.org/medicines/414 dapagliflozin 2021 Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 false false https://list.essentialmeds.org/medicines/613 dapsone 1977 Antileprosy medicines Antileprosy medicines 1 Leprosy 1 J04BA02 Oral > Solid: 100 mg tablet; 50 mg tablet; 25 mg tablet false false https://list.essentialmeds.org/medicines/293 darbepoetin alfa 2017 Antianaemia medicines Antianaemia medicines 1 Anaemia due to chronic disease 1 false true https://list.essentialmeds.org/medicines/418 darunavir 2015 Antiretrovirals > Protease inhibitors Antiretrovirals > Protease inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AE10 Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg false false https://list.essentialmeds.org/medicines/458 dasatinib 2017 Targeted therapies Targeted therapies 1 Chronic myelogenous leukaemia, BCR-ABL1-positive 1 L01EA02 Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet true false https://list.essentialmeds.org/medicines/84 daunorubicin 1999 Cytotoxic medicines Cytotoxic medicines 1 Acute myeloid leukaemia with recurrent genetic abnormalities; Lymphoid leukaemia, not elsewhere classified; Myeloid leukaemia 3 L01DB02 Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per mL in vial (as hydrochloride); 5 mg per mL in vial (as hydrochloride) true false https://list.essentialmeds.org/medicines/85 deferasirox 2023 Medicines for haemoglobinopathies Medicines for haemoglobinopathies 1 Other specified sickle cell disorders or other haemoglobinopathies; Thalassaemias 2 V03AC03 Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg Oral > Solid > tablet: 90 mg; 180 mg; 360 mg false false https://list.essentialmeds.org/medicines/643 deferiprone 2023 Medicines for haemoglobinopathies Medicines for haemoglobinopathies 1 Other specified sickle cell disorders or other haemoglobinopathies; Thalassaemias 2 false false https://list.essentialmeds.org/medicines/916 deferoxamine 1979 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific; Medicines for haemoglobinopathies 2 Harmful effects of drugs, medicaments or biological substances, not elsewhere classified; Other specified sickle cell disorders or other haemoglobinopathies; Thalassaemias 3 V03AC01 Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate) false false https://list.essentialmeds.org/medicines/40 delamanid 2015 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J04AK06 Oral > Solid > dispersible tablet: 25 mg Oral > Solid > tablet: 50 mg false false https://list.essentialmeds.org/medicines/280 dengue vaccine 2019 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BX04 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/434 desmopressin 1991 Medicines affecting coagulation Medicines affecting coagulation 1 Haemophilia A; Von Willebrand disease 2 H01BA02 Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate) Local > Nasal > Spray: 150 µg per actuation (acetate) false false https://list.essentialmeds.org/medicines/129 dexamethasone 1977 Other medicines administered to the mother Other medicines administered to the mother; Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Medicines for other common symptoms in palliative care; Antiemetic medicines 5 Respiratory distress syndrome of the newborn, altered by maternal corticosteroid therapy; Anaplastic large cell lymphoma, ALK-negative; Lymphoid leukaemia, not elsewhere classified; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-positive; Allergic or hypersensitivity conditions of unspecified type; Palliative care; Nausea or vomiting 9 H02AB02, L01AA01, C05AA09 Parenteral > General injections > unspecified: 4 mg per mL (dexamethasone phosphate (as sodium)); Oral > Liquid: 2 mg per 5 mL Oral > Solid: 2 mg; 4 mg Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (as disodium phosophate salt) Oral > Liquid: 2 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base) Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base Oral > Solid > tablet: 4 mg (as dexamethasone base); Oral > Liquid: 0.5 mg per 5 mL (as sodium phosphate); 2 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base) Oral > Solid > tablet: 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 2 mg (as dexamethasone base); 4 mg (as dexamethasone base); Oral > Liquid: 2 mg per 5 mL (as sodium phosphate); 0.5 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (dexamethasone phosphate (as sodium phosphate) equialent to 3.3 mg dexamethasone base) Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base); 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); Oral > Liquid: 0.5 mg per 5 mL (as sodium phosphate); 2 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base) Oral > Solid > tablet: 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 4 mg (as dexamethasone base); 2 mg (as dexamethasone base) true false https://list.essentialmeds.org/medicines/21 dextran 70 1979 Plasma substitutes Plasma substitutes 1 Hypovolaemia 1 B05AA05 Parenteral > General injections > IV: 6% injectable solution false false https://list.essentialmeds.org/medicines/472 diaphragms 1987 Barrier methods Barrier methods 1 Contact with health services for contraceptive management 1 - false false https://list.essentialmeds.org/medicines/423 diazepam 1977 Antiseizure medicines Antiseizure medicines; Medicines for other common symptoms in palliative care; Medicines for anxiety disorders 3 Status epilepticus; Palliative care; Anxiety 3 N05BA01 Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube; Oral > Liquid: 2 mg per 5 mL Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube Parenteral > General injections > unspecified: 5 mg per mL Oral > Solid > tablet: 5 mg (scored); 10 mg (scored); 2 mg (scored); Oral > Solid: 5 mg (scored); 2 mg (scored) false false https://list.essentialmeds.org/medicines/22 diazoxide 2019 Medicines for hypoglycaemia Medicines for hypoglycaemia 1 Persistent hyperinsulinaemic hypoglycaemia of infancy 1 V03AH01 Oral > Liquid: 50 mg per mL Oral > Solid: 50 mg false false https://list.essentialmeds.org/medicines/505 dicloxacillin 2023 Access group antibiotics Access group antibiotics 1 Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock 4 J01CF02 false false https://list.essentialmeds.org/medicines/724 diethylcarbamazine 1979 Antifilarials Antifilarials 1 Lymphatic filariasis 1 P02CB02 Oral > Solid: 50 mg tablet (dihydrogen citrate); 100 mg tablet (dihydrogen citrate) false false https://list.essentialmeds.org/medicines/64 digoxin 1977 Antiarrhythmic medicines Antiarrhythmic medicines; Medicines used in heart failure 2 Cardiac arrhythmia; Heart failure 2 C01AA05 Parenteral > General injections > IV: 250 µg per mL in 2 mL ampoule Oral > Liquid: 50 µg per mL Oral > Solid: 62.5 µg; 250 µg; Parenteral > General injections > IV: 250 µg per mL in 2 mL ampoule; 100 µg per mL in 1 mL ampoule Oral > Liquid: 50 µg per mL Oral > Solid > tablet: 62.5 µg; 250 µg; 125 µg false false https://list.essentialmeds.org/medicines/134 dihydroartemisinin + piperaquine 2017 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 2 P01BF05 Oral > Solid > dispersible tablet: 20 mg + 160 mg (phosphate); 40 mg + 320 mg (phosphate) Oral > Solid > tablet: 40 mg + 320 mg (phosphate); 20 mg + 160 mg (phosphate); 60 mg + 480 (phosphate); 80 mg + 640 mg (phosphate) false false https://list.essentialmeds.org/medicines/378 diloxanide 1977 Antiamoebic and antigiardiasis medicines Antiamoebic and antigiardiasis medicines 1 Amoebiasis 1 P01AC01 Oral > Solid: 500 mg (furoate) false false https://list.essentialmeds.org/medicines/363 dimercaprol 1977 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 V03AB09 Parenteral > General injections > IM: 50 mg per mL in 2 mL ampoule; 100 mg per mL in 3 mL ampoule false false https://list.essentialmeds.org/medicines/41 dinoprostone (prostaglandin E2) 2009 Medicines administered to the neonate [c] Medicines administered to the neonate [c] 1 Other specified congenital anomaly of great arteries including arterial duct 1 Parenteral > General injections > IV: 1 mg per mL false false https://list.essentialmeds.org/medicines/428 diphtheria antitoxin 1977 Immunologicals > Sera, immunoglobulins and monoclonal antibodies Immunologicals > Sera, immunoglobulins and monoclonal antibodies 1 Need for immunization against diphtheria alone 1 J06AA01 Parenteral > General injections > IM: 10000 IU in vial; 20000 IU in vial false true https://list.essentialmeds.org/medicines/511 diphtheria vaccine 1999 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against diphtheria alone 1 J07AF01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/430 docetaxel 2011 Cytotoxic medicines Cytotoxic medicines 1 Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Malignant neoplasms of prostate 3 L01CD02 Parenteral > General injections > IV: 20 mg per mL; 40 mg per mL true false https://list.essentialmeds.org/medicines/86 docusate sodium 2009 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care 1 Palliative care 1 A06AA02 Oral > Liquid: 50 mg per 5 mL; 12.5 mg per 5 mL Oral > Solid > capsule: 100 mg false false https://list.essentialmeds.org/medicines/23 dolasetron 2025 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Antiemetic medicines 2 Palliative care; Nausea or vomiting 2 false false https://list.essentialmeds.org/medicines/629 dolutegravir 2017 Antiretrovirals > Integrase inhibitors Antiretrovirals > Integrase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AJ03 Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored) false false https://list.essentialmeds.org/medicines/278 dolutegravir + lamivudine + tenofovir 2019 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR27 Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) false false https://list.essentialmeds.org/medicines/483 dopamine 1977 Medicines used in heart failure Medicines used in heart failure 1 Cardiogenic shock; Heart failure 2 C01CA04 Parenteral > General injections > IV: 40 mg per mL in 5 mL vial (hydrochloride) false false https://list.essentialmeds.org/medicines/145 doxorubicin 1977 Cytotoxic medicines Cytotoxic medicines 1 Diffuse large B-cell lymphoma, not otherwise specified; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Osteosarcoma of bone or articular cartilage of unspecified sites; Kaposi sarcoma of unspecified primary site; Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Hodgkin lymphoma; Follicular lymphoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis 14 L01DB01, L01AA01 Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per mL in 5 mL vial (hydrochloride); 2 mg per mL in 25 mL vial (hydrochloride) Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride) true false https://list.essentialmeds.org/medicines/87 doxorubicin (as pegylated liposomal) 2023 Cytotoxic medicines Cytotoxic medicines 1 Kaposi sarcoma of unspecified primary site 1 L01DB01 Parenteral > General injections > IV: 2 mg per mL in 10 mL vial (hydrochloride); 2 mg per mL in 25 mL vial (hydrochloride) true false https://list.essentialmeds.org/medicines/906 doxycycline 1977 Access group antibiotics Access group antibiotics; Antimalarial medicines > Medicines for chemoprophylaxis in travellers 2 Cholera; Chlamydia trachomatis; Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Cholera [children]; Chronic obstructive pulmonary disease with acute exacerbation; Malaria due to Plasmodium falciparum 6 J01AA02 Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium) Parenteral > General injections > unspecified: 100 mg in vial powder for injection Oral > Solid > dispersible tablet: 100 mg (as monohydrate) Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate) Oral > Solid > dosage form: 100 mg (as hyclate) Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous) Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate); Oral > Liquid: 50 mg per 5 mL (calcium); 25 mg per 5 mL (monohydrate) powder for oral liquid Oral > Solid > dispersible tablet: 100 mg (as monohydrate) Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate) false false https://list.essentialmeds.org/medicines/318 dulaglutide Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 false true https://list.essentialmeds.org/medicines/972 edoxaban 2019 Medicines affecting coagulation Medicines affecting coagulation 1 Other specified atrial fibrillation; Venous thromboembolism 2 false false https://list.essentialmeds.org/medicines/480 efavirenz 2002 Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AG03 Oral > Solid: 600 mg tablet false false https://list.essentialmeds.org/medicines/450 efavirenz + emtricitabine + tenofovir 2007 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR06 Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) false false https://list.essentialmeds.org/medicines/463 efavirenz + lamivudine + tenofovir 2017 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR11 Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil) false false https://list.essentialmeds.org/medicines/285 eflornithine 1991 Medicines for the treatment of 2nd stage African trypanosomiasis Medicines for the treatment of 2nd stage African trypanosomiasis 1 Gambiense trypanosomiasis 1 P01CX03 Parenteral > General injections > IV: 200 mg per mL in 50 mL bottle (hydrochloride) false false https://list.essentialmeds.org/medicines/388 eletriptan 2025 Medicines for acute migraine attacks Medicines for acute migraine attacks 1 Migraine 1 Oral > Solid > tablet: 40 mg false false https://list.essentialmeds.org/medicines/990 elexacaftor + tezacaftor + ivacaftor 2025 Medicines for cystic fibrosis Medicines for cystic fibrosis 1 Cystic fibrosis 1 R07AX32 Oral > Solid > tablet: 50 mg + 25 mg + 37.5 mg; 100 mg + 50 mg + 75 mg Oral > Solid > granules: 80 mg + 40 mg + 60 mg in sachet; 100 mg + 50 mg + 75 mg in sachet false false https://list.essentialmeds.org/medicines/954 emicizumab 2025 Medicines affecting coagulation Medicines affecting coagulation 1 Haemophilia A 1 B02BX06 Parenteral > General injections > SC: 12 mg per 0.4 mL in vial; 30 mg per mL in mL vial; 60 mg per 0.4 mL in vial; 105 mg per 0.7 mL in vial; 150 mg per mL in vial; 300 mg per 2 mL in vial false true https://list.essentialmeds.org/medicines/955 empagliflozin 2021 Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 A10BK03 Oral > Solid: 10 mg; 25 mg false false https://list.essentialmeds.org/medicines/614 emtricitabine + tenofovir 2007 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Contact with or exposure to human immunodeficiency virus; Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 2 J05AR03 Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) false false https://list.essentialmeds.org/medicines/467 enalapril 2003 Antihypertensive medicines Antihypertensive medicines; Medicines used in heart failure 2 Essential hypertension; Heart failure 2 C09AA02 Oral > Liquid: 1 mg per mL (as hydrogen maleate) Oral > Solid > tablet: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate); 10 mg (as hydrogen maleate); Oral > Solid > tablet: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate); 10 mg (as hydrogen maleate) false false https://list.essentialmeds.org/medicines/137 enoxaparin 2015 Medicines affecting coagulation Medicines affecting coagulation 1 Acute ischaemic heart disease; Venous thromboembolism 2 B01AB05 Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule false true https://list.essentialmeds.org/medicines/123 entecavir 2015 Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors 1 Chronic hepatitis B 1 J05AF10 Oral > Liquid: 0.05 mg per mL Oral > Solid: 0.5 mg; 1 mg false false https://list.essentialmeds.org/medicines/490 enzalutamide Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of prostate 1 Oral > Solid: 40 mg true false https://list.essentialmeds.org/medicines/455 ephedrine 1997 Local anaesthetics Local anaesthetics 1 Cardiac complications of anaesthesia during labour or delivery 1 C01CA26 Parenteral > Locoregional injections > Spinal anaesthesia: 30 mg per mL in 1 mL ampoule (ephedrine hydrochloride) false false https://list.essentialmeds.org/medicines/9 epinephrine 1977 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease; Antiallergics and medicines used in anaphylaxis; Antiarrhythmic medicines; Ophthalmological preparations > Mydriatics 4 Chronic obstructive pulmonary disease; Asthma; Anaphylaxis; Cardiac arrest; Primary open-angle glaucoma 5 R03AA01, C01CA24, S01EA01 Parenteral > General injections > unspecified: 1 mg per mL in ampoule (as hydrochloride or hydrogen tartrate); Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (as hydrochloride or hydrogen tartrate); Parenteral > General injections > IV: 100 µg per mL in 10 mL ampoule (as acid tartrate or hydrochloride); Local > Ophthalmological > Solution (eye drops): 2% (as hydrochloride) false false https://list.essentialmeds.org/medicines/32 epoetin alfa 2017 Antianaemia medicines Antianaemia medicines 1 Anaemia due to chronic disease 1 false true https://list.essentialmeds.org/medicines/415 epoetin beta 2017 Antianaemia medicines Antianaemia medicines 1 Anaemia due to chronic disease 1 false true https://list.essentialmeds.org/medicines/416 epoetin theta 2017 Antianaemia medicines Antianaemia medicines 1 Anaemia due to chronic disease 1 false true https://list.essentialmeds.org/medicines/417 equine rabies immunoglobulin 2021 Immunologicals > Sera, immunoglobulins and monoclonal antibodies Immunologicals > Sera, immunoglobulins and monoclonal antibodies 1 Rabies 1 J06BB05 Parenteral > Locoregional injections > Intradermal: 150 IU per mL in vial; 200 IU per mL in vial; 300 IU per mL in vial; 400 IU per mL in vial false true https://list.essentialmeds.org/medicines/605 ergocalciferol 1977 Vitamins and minerals Vitamins and minerals 1 Calcium deficiency; Vitamin D deficiency 2 A11CC01 Oral > Liquid: 250 µg per mL (10 000 IU per mL) Oral > Solid: 1.25 mg (50 000 IU) false false https://list.essentialmeds.org/medicines/262 ergometrine 1977 Uterotonics Uterotonics 1 Postpartum haemorrhage 1 G02AB03 Parenteral > General injections > unspecified: 200 µg in 1 mL ampoule (hydrogen maleate) false false https://list.essentialmeds.org/medicines/239 erlotinib 2019 Targeted therapies Targeted therapies 1 Other specified malignant neoplasms of bronchus or lung 1 L01EB02 Oral > Solid: 100 mg; 150 mg true false https://list.essentialmeds.org/medicines/405 erythromycin 1977 Watch group antibiotics Watch group antibiotics; Ophthalmological preparations > Anti-infective agents 2 Acute pharyngitis; Chlamydial conjunctivitis; Gonococcal infection of eye 3 J01FA09, S01AA17 Parenteral > General injections > IV: 500 mg in vial powder for injection (as lactobionate) Oral > Liquid: 125 mg per 5 mL (as stearate or ethylsuccinate) Oral > Solid: 250 mg (as stearate or ethylsuccinate); Local > Ophthalmological > Ointment: 0.5% false false https://list.essentialmeds.org/medicines/228 erythropoiesis-stimulating agents 2017 Antianaemia medicines Antianaemia medicines 1 Anaemia due to chronic disease 1 B03XA03, B03XA01, B03XA02 Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe false true https://list.essentialmeds.org/medicines/122 escitalopram 2023 Medicines for anxiety disorders Medicines for anxiety disorders 1 Generalised anxiety disorder 1 false false https://list.essentialmeds.org/medicines/660 estradiol cypionate + medroxyprogesterone acetate 2007 Injectable hormonal contraceptives Injectable hormonal contraceptives 1 Contact with health services for reasons associated with reproduction 1 G03AA08 Parenteral > General injections > IM: 5 mg + 25 mg false false https://list.essentialmeds.org/medicines/188 etanercept 2023 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation 3 Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type 5 false true https://list.essentialmeds.org/medicines/548 ethambutol 1977 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AK02 Parenteral > General injections > IV: 1000 mg per 10 mL; 2000 mg per 20 mL Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 100 mg (hydrochloride); 400 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/321 ethambutol + isoniazid + pyrazinamide + rifampicin 1999 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AM06 Oral > Solid: 275 mg + 75 mg + 400 mg + 150 mg tablet false false https://list.essentialmeds.org/medicines/323 ethambutol + isoniazid + rifampicin 2007 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AK02, J04AC01, J04AB02 Oral > Solid: 275 mg + 75 mg + 150 mg tablet false false https://list.essentialmeds.org/medicines/324 ethanol 1999 Antiseptics Antiseptics 1 Denatured alcohol 1 D08AX08 Local > Topical > Solution: 70% (denatured) false false https://list.essentialmeds.org/medicines/171 ethinylestradiol + etonogestrel 2021 Intravaginal contraceptives Intravaginal contraceptives 1 Contact with health services for contraceptive management 1 G02BB01 Local > Vaginal > vaginal ring: 2.7 mg + 11.7 mg false false https://list.essentialmeds.org/medicines/677 ethinylestradiol + levonorgestrel 1979 Oral hormonal contraceptives Oral hormonal contraceptives 1 Contact with health services for contraceptive management 1 G03AA07 Oral > Solid: 50 µg + 250 µg [4] Oral > Solid: 30 µg + 150 µg false false https://list.essentialmeds.org/medicines/184 ethinylestradiol + norethisterone 1977 Oral hormonal contraceptives Oral hormonal contraceptives 1 Contact with health services for contraceptive management 1 G03AA05 Oral > Solid: 35 µg + 1 mg false false https://list.essentialmeds.org/medicines/185 ethionamide 1982 Antituberculosis medicines Antituberculosis medicines 1 Tuberculous meningitis; Multi-drug resistant Mycobacterium tuberculosis 2 J04AD03 Oral > Solid > dispersible tablet: 125 mg Oral > Solid > tablet: 250 mg false false https://list.essentialmeds.org/medicines/351 ethosuximide 1977 Antiseizure medicines Antiseizure medicines 1 Absence seizures, typical 1 N03AD01 Oral > Liquid: 250 mg per 5 mL Oral > Solid: 250 mg false false https://list.essentialmeds.org/medicines/56 etonogestrel-releasing implant 2015 Implantable contraceptives Implantable contraceptives 1 Contact with health services for insertion of contraceptive device 1 G03AC08 Implant > Subdermal: 68 mg single rod false false https://list.essentialmeds.org/medicines/192 etoposide 1984 Cytotoxic medicines Cytotoxic medicines 1 Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Myeloid leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Germ cell tumour of testis; Osteosarcoma of bone or articular cartilage of unspecified sites; Other specified malignant neoplasms of the ovary; Other specified malignant neoplasms of bronchus or lung; Hodgkin lymphoma; Malignant trophoblastic neoplasms of placenta; Retinoblastoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis 14 L01CB01 Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate) Oral > Solid: 100 mg capsule; 50 mg capsule Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule Oral > Solid: 100 mg capsule true false https://list.essentialmeds.org/medicines/88 everolimus 2021 Targeted therapies Targeted therapies 1 Other specified gliomas of brain 1 L01EG02 Oral > Solid > dispersible tablet: 2 mg; 3 mg; 5 mg Oral > Solid > tablet: 2.5 mg; 5 mg; 7.5 mg; 10 mg true false https://list.essentialmeds.org/medicines/615 fentanyl 2017 Opioid analgesics Opioid analgesics 1 Chronic cancer pain 1 N01AH01 Oral > Solid: 100 to 800 µg sub-lingual tablet (as citrate); 200 to 1600 µg lozenge (as citrate) Oral > Other: 200 to 1200 µg buccal film (as citrate) Local > Topical > Transdermal patch: 12 µg/hour; 25 µg/hour; 50 µg/hour; 75 µg/hour; 100 µg/hour true false https://list.essentialmeds.org/medicines/17 ferrous salt 1977 Antianaemia medicines Antianaemia medicines 1 Iron deficiency anaemia 1 B03AA07, B03AA02 Oral > Liquid: 25 mg per mL elemental iron; 9 mg per mL elemental iron Oral > Solid > tablet: 60 to 65 mg elemental iron false false https://list.essentialmeds.org/medicines/118 ferrous salt + folic acid 1982 Antianaemia medicines Antianaemia medicines 1 Iron deficiency anaemia; Spina bifida; Clefts of lip, alveolus or palate; Anencephaly or similar anomalies 4 B03AD03, B03AD02, B03AD05 Oral > Solid: 60 mg iron + 2.8 mg Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg false false https://list.essentialmeds.org/medicines/394 fexinidazole 2019 Medicines for the treatment of 1st stage African trypanosomiasis Medicines for the treatment of 1st stage African trypanosomiasis; Medicines for the treatment of 2nd stage African trypanosomiasis 2 Rhodesiense trypanosomiasis; Gambiense trypanosomiasis 2 P01CA03 Oral > Solid > tablet: 600 mg Oral > Solid: 600 mg false false https://list.essentialmeds.org/medicines/557 fexofenadine 2025 Antiallergics and medicines used in anaphylaxis Antiallergics and medicines used in anaphylaxis 1 Allergic or hypersensitivity conditions of unspecified type 1 false false https://list.essentialmeds.org/medicines/634 filgrastim 2015 Immunomodulators Immunomodulators 1 Acquired neutropaenia 1 L03AA02 Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial true true https://list.essentialmeds.org/medicines/89 flucloxacillin 2023 Access group antibiotics Access group antibiotics 1 Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock 4 J01CF02 false false https://list.essentialmeds.org/medicines/732 fluconazole 1999 Antifungal medicines Antifungal medicines 1 Cryptococcosis; Candidosis 2 J02AC01 Parenteral > General injections > IV: 2 mg per mL in vial Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid Oral > Solid > capsule: 50 mg false false https://list.essentialmeds.org/medicines/359 flucytosine 1977 Antifungal medicines Antifungal medicines 1 Cryptococcosis 1 J02AX01 Parenteral > General injections > IV: 2.5 g per 250 mL infusion Oral > Solid: 250 mg capsule false false https://list.essentialmeds.org/medicines/360 fludarabine 2015 Cytotoxic medicines Cytotoxic medicines 1 Chronic lymphocytic leukaemia or small lymphocytic lymphoma 1 L01BB05 Parenteral > General injections > IV: 50 mg in vial (fludarabine phosphate) powder for injection Oral > Solid: 10 mg tablet (fludarabine phosphate) true false https://list.essentialmeds.org/medicines/90 fludrocortisone 1977 Adrenal hormones and synthetic substitutes Adrenal hormones and synthetic substitutes 1 Adrenocortical insufficiency 1 H02AA02 Oral > Liquid: 100 µg per mL Oral > Solid > tablet: 100 µg (acetate) false false https://list.essentialmeds.org/medicines/182 fluorescein 1979 Diagnostic agents > Ophthalmic medicines Diagnostic agents > Ophthalmic medicines 1 Fluorescein 1 S01JA01 Local > Ophthalmological > Solution (eye drops): 1% (sodium salt) false false https://list.essentialmeds.org/medicines/164 fluoride 1979 Dental medicines and preparations Dental medicines and preparations 1 Dental caries 1 A01AA01, A01AA04 Local > Dental > Gel: 2500 to 12500 ppm fluoride (any type) Local > Dental > Toothpaste, cream or gel: 1000 to 1500 ppm fluoride (any type) Local > Dental > Mouthrinse: 230 to 900 ppm fluoride (any type) Local > Dental > Varnish: 22500 ppm fluoride (any type) false false https://list.essentialmeds.org/medicines/268 fluorouracil 1977 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation; Cytotoxic medicines 2 Plantar warts; Malignant neoplasms of nasopharynx; Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of breast; Malignant neoplasms of colon 6 L01BC02 Local > Topical > Ointment: 5%; Parenteral > General injections > IV: 50 mg per mL in vial Parenteral > General injections > IV: 50 mg per mL in 5 mL ampoule true false https://list.essentialmeds.org/medicines/91 fluoxetine 2007 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Medicines for depressive disorders; Medicines for anxiety disorders; Medicines for obsessive compulsive disorders 4 Palliative care; Depressive disorders; Generalised anxiety disorder; Social anxiety disorder; Panic disorder; Obsessive-compulsive disorder 6 N06AB03 Oral > Solid: 20 mg (as hydrochloride) false false https://list.essentialmeds.org/medicines/24 fluphenazine 1977 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 N05AB02 Parenteral > General injections > IM: 25 mg per mL in ampoule (decanoate); 25 mg per mL in ampoule (enanthate) false false https://list.essentialmeds.org/medicines/245 flutamide 2021 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of prostate 1 true false https://list.essentialmeds.org/medicines/640 fluticasone 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/666 fluticasone + formoterol 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/671 fluticasone furoate + vilanterol 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/672 fluvastatin 2021 Lipid-lowering agents Lipid-lowering agents 1 Mixed hyperlipidaemia; Coronary atherosclerosis 2 false false https://list.essentialmeds.org/medicines/528 fluvoxamine 2023 Medicines for anxiety disorders Medicines for anxiety disorders 1 Generalised anxiety disorder 1 false false https://list.essentialmeds.org/medicines/661 folic acid 1977 Antianaemia medicines Antianaemia medicines 1 Cephalocele; Anencephaly or similar anomalies; Spina bifida; Folate deficiency anaemia 4 B03BB01 Oral > Solid: 400 µg Oral > Liquid: 1 mg per mL Oral > Solid: 1 mg tablet; 5 mg tablet false false https://list.essentialmeds.org/medicines/120 fomepizole 2013 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 V03AB34 Parenteral > General injections > IV: 5 mg per mL in 20 mL ampoule or vial (sulfate); 1 g per mL in 1.5 mL ampoule or vial (base) false false https://list.essentialmeds.org/medicines/46 fosfomycin (injection) 2017 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem resistant Acinetobacter baumannii; Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales 3 J01XX01 Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection false false https://list.essentialmeds.org/medicines/343 fresh-frozen plasma 2013 Blood and blood components Blood and blood components 1 Blood transfusion without reported diagnosis 1 B05AX03 Parenteral > General injections > IV: false true https://list.essentialmeds.org/medicines/454 furosemide 1977 Diuretics Diuretics; Medicines used in heart failure 2 Anuria or oliguria; Oedema; Heart failure 3 C03CA01 Parenteral > General injections > IV: 10 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule Oral > Liquid: 20 mg per 5 mL; 50 mg per 5 mL Oral > Solid > tablet: 40 mg; 20 mg false false https://list.essentialmeds.org/medicines/143 gefitinib 2019 Targeted therapies Targeted therapies 1 Other specified malignant neoplasms of bronchus or lung 1 true false https://list.essentialmeds.org/medicines/403 gemcitabine 2015 Cytotoxic medicines Cytotoxic medicines 1 Other specified carcinomas of ovary; Other specified malignant neoplasms of bronchus or lung 2 L01BC05 Parenteral > General injections > IV: 200 mg in vial powder for injection; 1 g in vial powder for injection true false https://list.essentialmeds.org/medicines/92 gentamicin 1977 Access group antibiotics Access group antibiotics; Ophthalmological preparations > Anti-infective agents; Medicines for bacterial central nervous system infections 3 Acute malnutrition in infants, children or adolescents (complicated) [children]; Neonatal meningitis; Sepsis without septic shock; Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Other specified prophylactic measures; Gonococcal infection; Other specified conjunctivitis; Infectious blepharitis 12 J01GB03, S02AA14 Parenteral > General injections > unspecified: 10 mg per mL in 2 mL vial (as sulfate); 40 mg per mL in 2 mL vial (as sulfate); Local > Ophthalmological > Solution (eye drops): 0.3% (gentamicin sulfate) benzylpenicillin; ampicillin; amoxicillin false false https://list.essentialmeds.org/medicines/229 glass ionomer cement 2021 Dental medicines and preparations Dental medicines and preparations 1 Dental caries 1 Local > Dental > Powder + liquid: Single-use capsules: 0.4 g powder + 0.09 mL liquid; Multi-use bottle: powder + liquid false false https://list.essentialmeds.org/medicines/616 glatiramer acetate 2023 Medicines for multiple sclerosis Medicines for multiple sclerosis 1 Multiple sclerosis 1 L03AX13 Parenteral > General injections > SC: 20 mg per mL; 40 mg per mL Parenteral > General injections > SC: 20 mg per mL in pre-filled syringe; 40 mg per mL in pre-filled syringe false false https://list.essentialmeds.org/medicines/568 glecaprevir + pibrentasvir 2019 Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP57 Oral > Solid: 50 mg + 20 mg granules Oral > Solid > tablet: 100 mg + 40 mg false false https://list.essentialmeds.org/medicines/491 gliclazide 2013 Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 A10BB09 Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release false false https://list.essentialmeds.org/medicines/194 glucagon 2011 Medicines for hypoglycaemia Medicines for hypoglycaemia 1 Hypoglycaemia in the context of diabetes 1 H04AA01 Parenteral > General injections > unspecified: 1 mg per mL as powder and diluent false false https://list.essentialmeds.org/medicines/195 glucose 1977 Solutions correcting water, electrolyte and acid-base disturbances > Parenteral Solutions correcting water, electrolyte and acid-base disturbances > Parenteral 1 Hypoglycaemia without associated diabetes; Other specified disorders of fluid, electrolyte or acid-base balance 2 B05CX01 Parenteral > General injections > IV: 50% hypertonic Parenteral > General injections > IV: 5% isotonic; 10% hypertonic false false https://list.essentialmeds.org/medicines/256 glucose + sodium chloride 1979 Solutions correcting water, electrolyte and acid-base disturbances > Parenteral Solutions correcting water, electrolyte and acid-base disturbances > Parenteral 1 Other specified disorders of fluid, electrolyte or acid-base balance 1 B05BB02 Parenteral > General injections > IV: 4% + 0.18% (equivalent to Na+ 30 mmol/L and Cl- 30 mmol/L; 5% + 0.9% (equivalent to Na+ 150 mmol/L and Cl- 150 mmol/L); 5% + 0.45% (equivalent to Na+ 75 mmol/L and Cl- 75 mmol/L) false false https://list.essentialmeds.org/medicines/542 glutaral 1991 Disinfectants Disinfectants 1 Glutaral nonmedicinal 1 V07AV Local > Topical > Solution: 2% false false https://list.essentialmeds.org/medicines/525 glycerol 2025 Dermatological medicines > Moisturizers Dermatological medicines > Moisturizers 1 Atopic eczema 1 Local > Topical > Cream: 15 to 20% false false https://list.essentialmeds.org/medicines/956 glyceryl trinitrate 1977 Antianginal medicines Antianginal medicines 1 Angina pectoris 1 C01DA02 Oral > Solid: 500 µg sublingual tablet false false https://list.essentialmeds.org/medicines/131 glycopyrronium 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease 1 false false https://list.essentialmeds.org/medicines/675 golimumab 2023 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases 2 Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis 4 false true https://list.essentialmeds.org/medicines/551 goserelin 2021 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of breast; Malignant neoplasms of prostate 2 true false https://list.essentialmeds.org/medicines/873 granisetron 2025 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Antiemetic medicines 2 Palliative care; Nausea or vomiting 2 false false https://list.essentialmeds.org/medicines/630 griseofulvin 1977 Antifungal medicines Antifungal medicines 1 Dermatophytosis 1 D01BA01 Oral > Liquid: 125 mg per 5 mL Oral > Solid: 125 mg; 250 mg false false https://list.essentialmeds.org/medicines/361 haemophilus influenzae type b vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against single bacterial diseases 1 J07AG01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/206 haloperidol 1977 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Medicines for psychotic disorders 2 Palliative care; Schizophrenia or other primary psychotic disorders 2 N05AD01 Oral > Liquid: 2 mg per mL Oral > Solid: 0.5 mg; 2 mg; 5 mg Parenteral > General injections > unspecified: 5 mg per mL in 1-mL ampoule; Parenteral > General injections > IM: 5 mg per mL in ampoule Oral > Solid: 2 mg; 5 mg false false https://list.essentialmeds.org/medicines/25 haloperidol decanoate 2023 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 false false https://list.essentialmeds.org/medicines/924 heparin sodium 1977 Medicines affecting coagulation Medicines affecting coagulation 1 Acute ischaemic heart disease; Unstable angina; Venous thromboembolism 3 B01AB01 Parenteral > General injections > IV: 1000 IU per mL in 1 mL ampoule or vial; 20000 IU per mL in 1 mL ampoule or vial; 5000 IU per mL in 1 mL ampoule or vial false false https://list.essentialmeds.org/medicines/124 hepatitis A vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against viral hepatitis 1 J07BC02 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/217 hepatitis B vaccine 1987 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against viral hepatitis 1 J07BC01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/207 hepatitis E vaccine 2025 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against viral hepatitis 1 All vaccines should comply with the WHO requirements for biological substances. false false https://list.essentialmeds.org/medicines/957 homatropine 1977 Ophthalmological preparations > Mydriatics Ophthalmological preparations > Mydriatics 1 Anterior uveitis 1 Local > Ophthalmological > Solution (eye drops): 2% (hydrobromide) false false https://list.essentialmeds.org/medicines/512 human papilloma virus (HPV) vaccine 2015 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BM01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/208 hydralazine 1977 Antihypertensive medicines Antihypertensive medicines 1 Gestational hypertension 1 C02DB02 Parenteral > General injections > IV: 20 mg in ampoule powder for injection (hydrochloride) Oral > Solid: 50 mg tablet; 25 mg tablet (hydrochloride) Oral > Solid: 50 mg (hydrochloride); 25 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/138 hydrochlorothiazide 1977 Antihypertensive medicines Antihypertensive medicines; Diuretics; Medicines used in heart failure 3 Essential hypertension; Oedema; Heart failure 3 C03AA03 Oral > Liquid: 50 mg per 5 mL Oral > Solid: 25 mg; 12.5 mg; Oral > Solid > dosage form: 25 mg; 12.5 mg; Oral > Liquid: 50 mg per 5 mL Oral > Solid: 25 mg false false https://list.essentialmeds.org/medicines/139 hydrocortisone 1977 Hormones and antihormones Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Anti-inflammatory medicines; Dermatological medicines > Anti-inflammatory and antipruritic medicines; Adrenal hormones and synthetic substitutes 5 Lymphoid leukaemia, not elsewhere classified; Burkitt lymphoma including Burkitt leukaemia; Anaphylaxis; Crohn disease site; Ulcerative colitis; Dermatitis or eczema; Pruritus due to skin disorder; Psoriasis of unspecified type; Lichen planus; Adrenocortical insufficiency 10 H02AB09, A07EA02, D07AA02 Parenteral > General injections > unspecified: 100 mg in vial (as sodium succinate); Parenteral > General injections > unspecified: 100 mg in vial powder for injection (as sodium succinate); Local > Rectal > Suppository: 25 mg (acetate) Local > Rectal > Retention enema: 100 mg per 60 mL; Local > Topical > Cream: 1% (acetate) Local > Topical > Ointment: 1% (acetate); Oral > Solid > tablet: 5 mg; 10 mg; 20 mg Oral > Solid > granules: 0.5 mg in capsule; 1 mg in capsule; 2 mg in capsule; 5 mg in capsule true false https://list.essentialmeds.org/medicines/33 hydromorphone 2025 Opioid analgesics Opioid analgesics 1 Pain 1 false false https://list.essentialmeds.org/medicines/560 hydroxocobalamin 1979 Antianaemia medicines Antianaemia medicines 1 Megaloblastic anaemia due to vitamin B12 deficiency 1 B03BA03 Parenteral > General injections > IM: 1 mg per mL in 1 mL ampoule (as acetate); 1 mg per mL in 1 mL ampoule (as hydrochloride); 1 mg per mL in 1 mL ampoule (as sulfate) false false https://list.essentialmeds.org/medicines/121 hydroxychloroquine 2011 Disease-modifying anti-rheumatic drugs (DMARDs) Disease-modifying anti-rheumatic drugs (DMARDs) 1 Systemic lupus erythematosus; Cutaneous lupus erythematosus of unspecified type 2 P01BA02 Oral > Solid: 200 mg (as sulfate) false false https://list.essentialmeds.org/medicines/276 hydroxyurea (hydroxycarbamide) 2009 Cytotoxic medicines Cytotoxic medicines; Medicines for haemoglobinopathies 2 Chronic myeloid leukaemia, not elsewhere classified; Other specified sickle cell disorders or other haemoglobinopathies 2 L01XX05 Oral > Solid: 200 mg; 250 mg; 300 mg; 400 mg; 500 mg; 1 g Oral > Solid > dosage form: 200 mg; 300 mg; 400 mg; 500 mg; 1 g; 100 mg; Oral > Solid > dosage form: 200 mg; 500 mg; 1 g; 100 mg true false https://list.essentialmeds.org/medicines/93 hyoscine butylbromide 2013 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care 1 Palliative care 1 A03BB01 Parenteral > General injections > unspecified: 20 mg per mL injection false false https://list.essentialmeds.org/medicines/26 hyoscine hydrobromide 2009 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care 1 Palliative care 1 A04AD01 Local > Topical > Transdermal patch: 1 mg per 72 hours transdermal patch Parenteral > General injections > unspecified: 400 µg per mL injection; 600 µg per mL injection false false https://list.essentialmeds.org/medicines/281 hypochlorous acid 2025 Disinfectants Disinfectants 1 Disinfectant, not elsewhere classified 1 V07AV Solution (aqueous): containing hypochlorous acid ≥ 150 parts per million false false https://list.essentialmeds.org/medicines/875 ibrutinib 2021 Targeted therapies Targeted therapies 1 Chronic lymphocytic leukaemia or small lymphocytic lymphoma 1 L01EL01 Oral > Solid: 140 mg true false https://list.essentialmeds.org/medicines/618 ibuprofen 1977 Medicines for acute migraine attacks Medicines for acute migraine attacks; Medicines administered to the neonate [c]; Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) 3 Migraine; Patent arterial duct; Pain 3 M01AE01, C01EB16 Oral > Liquid: 100 mg per 5 mL; 200 mg per 5 mL Oral > Solid > tablet: 200 mg; 400 mg; Parenteral > General injections > IV: 5 mg per mL; Oral > Liquid: 200 mg per 5 mL; 100 mg per 5 mL Oral > Solid > tablet: 200 mg; 400 mg; 600 mg false false https://list.essentialmeds.org/medicines/14 ifosfamide 2009 Cytotoxic medicines Cytotoxic medicines 1 Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Rhabdomyosarcoma primary site; Osteosarcoma of bone or articular cartilage of unspecified sites; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis 9 L01AA06 Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection true false https://list.essentialmeds.org/medicines/94 imatinib 2015 Targeted therapies Targeted therapies 1 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1; Chronic myeloid leukaemia, not elsewhere classified; Gastrointestinal stromal tumour of unspecified gastrointestinal sites 3 L01EA01 Oral > Solid: 100 mg; 400 mg true false https://list.essentialmeds.org/medicines/95 imipenem + cilastatin 1997 Watch group antibiotics Watch group antibiotics; Antituberculosis medicines 2 Peritoneal abscess (severe); Neutropaenia (high-risk); Peritonitis (severe); Multi-drug resistant Mycobacterium tuberculosis 4 J01DH02 Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection false false https://list.essentialmeds.org/medicines/600 indapamide 2021 Antihypertensive medicines Antihypertensive medicines; Medicines used in heart failure 2 Essential hypertension; Heart failure 2 false false https://list.essentialmeds.org/medicines/647 indometacin 2021 Medicines administered to the neonate [c] Medicines administered to the neonate [c] 1 Patent arterial duct 1 false false https://list.essentialmeds.org/medicines/427 infliximab 2023 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation 3 Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type 5 false true https://list.essentialmeds.org/medicines/549 influenza vaccine (seasonal) 1979 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against influenza 1 J07BB01, J07BB02, J07BB03 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/439 insulin (analogue, long-acting) 2021 Insulins Insulins 1 Type 2 diabetes mellitus; Type 1 diabetes mellitus 2 A10AE06, A10AE05, A10AE04 Parenteral > General injections > SC: 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution; 100 IU per mL in 10 mL vial solution false true https://list.essentialmeds.org/medicines/622 insulin (analogue, rapid-acting) 2025 Insulins Insulins 1 Type 1 diabetes mellitus; Type 2 diabetes mellitus 2 A10AB05, A10AB06, A10AB04 Parenteral > General injections > SC: 100 IU per 1 mL in 10 mL vial; 100 IU per 1 mL in 3 mL cartridge; 100 IU per 1 mL in 3 mL pre-filled pen false false https://list.essentialmeds.org/medicines/958 insulin (human, intermediate-acting) 1977 Insulins Insulins 1 Type 2 diabetes mellitus; Type 1 diabetes mellitus 2 A10AC01 Parenteral > General injections > SC: 40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin false true https://list.essentialmeds.org/medicines/197 insulin (human, short-acting) 1977 Insulins Insulins 1 Type 2 diabetes mellitus; Type 1 diabetes mellitus 2 A10AC01 Parenteral > General injections > SC: 40 IU per mL in 10 mL vial solution; 100 IU per mL in 10 mL vial solution; 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution false true https://list.essentialmeds.org/medicines/196 insulin aspart 2025 Insulins Insulins 1 Type 1 diabetes mellitus; Type 2 diabetes mellitus 2 Parenteral > General injections > SC: 100 IU per mL in 110 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen false false https://list.essentialmeds.org/medicines/965 insulin degludec Insulins Insulins 1 Type 2 diabetes mellitus; Type 1 diabetes mellitus 2 Parenteral > General injections > SC: 100 units per mL false true https://list.essentialmeds.org/medicines/575 insulin detemir Insulins Insulins 1 Type 2 diabetes mellitus; Type 1 diabetes mellitus 2 false true https://list.essentialmeds.org/medicines/574 insulin glargine Insulins Insulins 1 Type 2 diabetes mellitus; Type 1 diabetes mellitus 2 Parenteral > General injections > SC: 100 units per mL false true https://list.essentialmeds.org/medicines/573 insulin glulisine 2025 Insulins Insulins 1 Type 1 diabetes mellitus; Type 2 diabetes mellitus 2 Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen false false https://list.essentialmeds.org/medicines/966 insulin lispro 2025 Insulins Insulins 1 Type 1 diabetes mellitus; Type 2 diabetes mellitus 2 Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen false false https://list.essentialmeds.org/medicines/964 intraperitoneal dialysis solution 1977 Peritoneal dialysis solution Peritoneal dialysis solution 1 Care involving peritoneal dialysis 1 Solution: of appropriate composition in accordance with local clinical guidelines. false false https://list.essentialmeds.org/medicines/429 iodine 1989 Antiseptics Antiseptics; Vitamins and minerals 2 Povidone iodine; Iodine deficiency 2 H03CA Parenteral > General injections > IM: 480 mg per mL in 10 mL ampoule or vial iodized oil (oral or injectable) false false https://list.essentialmeds.org/medicines/263 iodine + potassium iodide (Lugol's solution) 2007 Thyroid hormones and antithyroid medicines Thyroid hormones and antithyroid medicines 1 Thyrotoxicosis 1 H03CA Oral > Liquid: 5% w/v + 10% w/v (aqueous) false false https://list.essentialmeds.org/medicines/202 iohexol 1984 Diagnostic agents > Radiocontrast media Diagnostic agents > Radiocontrast media 1 X-ray contrast media, iodinated 1 V08AB02 Parenteral > General injections > unspecified: 140 to 350 mg iodine per mL in 5 mL ampoule; 140 to 350 mg iodine per mL in 10 mL ampoule; 140 to 350 mg iodine per mL in 20 mL ampoule false false https://list.essentialmeds.org/medicines/168 ipratropium bromide 1997 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease; Asthma 2 R03BB01 Respiratory > Inhalation > solution: 20 µg per actuation in pressurized metered dose inhaler false false https://list.essentialmeds.org/medicines/253 irinotecan 2015 Cytotoxic medicines Cytotoxic medicines 1 Rhabdomyosarcoma primary site; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of kidney, except renal pelvis 3 L01CE02 Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial true false https://list.essentialmeds.org/medicines/96 isoflurane 2011 General anaesthetics and oxygen > Inhalational medicines General anaesthetics and oxygen > Inhalational medicines 1 Anaesthetics and therapeutic gases 1 N01AB06 Respiratory > Inhalation > liquid: false false https://list.essentialmeds.org/medicines/2 isoniazid 1977 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AC01 Parenteral > General injections > IV: 100 mg per mL Oral > Solid > dispersible tablet: 100 mg (scored) Oral > Solid > tablet: 100 mg; 300 mg false false https://list.essentialmeds.org/medicines/325 isoniazid + pyrazinamide + rifampicin 1997 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AM05 Oral > Solid > dispersible tablet: 50 mg + 150 mg + 75 mg false false https://list.essentialmeds.org/medicines/326 isoniazid + pyridoxine + sulfamethoxazole + trimethoprim 2017 Medicines for prevention of HIV-related opportunistic infections Medicines for prevention of HIV-related opportunistic infections 1 Other specified prophylactic measures 1 J04AC51 Oral > Solid: 300 mg + 25 mg + 800 mg + 160 mg tablet (scored) false false https://list.essentialmeds.org/medicines/286 isoniazid + rifampicin 1989 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AM02 Oral > Solid > dispersible tablet: 50 mg + 75 mg Oral > Solid > tablet: 75 mg + 150 mg; 150 mg + 300 mg false false https://list.essentialmeds.org/medicines/330 isoniazid + rifapentine 2021 Antituberculosis medicines Antituberculosis medicines 1 Latent tuberculosis 1 J04AC51 Oral > Solid: 300 mg + 300 mg tablet (scored) false false https://list.essentialmeds.org/medicines/627 isosorbide dinitrate 1977 Antianginal medicines Antianginal medicines 1 Angina pectoris 1 C01DA08 Oral > Solid: 5 mg sublingual tablet false false https://list.essentialmeds.org/medicines/132 itraconazole 2017 Antifungal medicines Antifungal medicines 1 Chronic pulmonary aspergillosis; Paracoccidioidomycosis; Sporotrichosis; Histoplasmosis; Talaromycosis; Chromoblastomycosis 6 J02AC02 Oral > Liquid: 10 mg per mL Oral > Solid: 100 mg false false https://list.essentialmeds.org/medicines/287 ivacaftor 2025 Medicines for cystic fibrosis Medicines for cystic fibrosis 1 Cystic fibrosis 1 R07AX02 Oral > Solid > tablet: 75 mg; 150 mg Oral > Solid > granules: 59.5 mg; 75 mg false false https://list.essentialmeds.org/medicines/959 ivermectin 1987 Intestinal anthelminthics Intestinal anthelminthics; Antifilarials; Medicines for ectoparasitic infections 3 Hookworm diseases; Strongyloidiasis; Trichuriasis; Ancylostomiasis; Ascariasis; Lymphatic filariasis; Onchocerciasis; Scabies 8 P02CF01 Oral > Solid > tablet: 3 mg false false https://list.essentialmeds.org/medicines/58 kanamycin 2021 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Other specified conjunctivitis; Infectious blepharitis 2 false false https://list.essentialmeds.org/medicines/876 ketamine 1984 General anaesthetics and oxygen > Injectable medicines General anaesthetics and oxygen > Injectable medicines 1 Anaesthetics and therapeutic gases 1 N01AX03 Parenteral > General injections > unspecified: 10 mg per mL in vial (as hydrochloride); 50 mg per mL in vial (as hydrochloride) false false https://list.essentialmeds.org/medicines/5 lactulose 2011 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care 1 Palliative care 1 A06AD11 Oral > Liquid: 3.3 to 3.4 g per 5 mL oral liquid false false https://list.essentialmeds.org/medicines/27 lamivudine 2002 Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AF05 Oral > Liquid: 50 mg per 5 mL Oral > Solid: 150 mg tablet false false https://list.essentialmeds.org/medicines/364 lamivudine + tenofovir 2021 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Contact with or exposure to human immunodeficiency virus; Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 2 false false https://list.essentialmeds.org/medicines/638 lamivudine + zidovudine 2007 Fixed-dose combinations of antiretrovirals Fixed-dose combinations of antiretrovirals 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR01 Oral > Solid: 30 mg + 60 mg Tablet; 150 mg + 300 mg Tablet false false https://list.essentialmeds.org/medicines/470 lamotrigine 2017 Antiseizure medicines Antiseizure medicines 1 Epilepsy or seizures 1 N03AX09 Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible) false false https://list.essentialmeds.org/medicines/50 latanoprost 2013 Ophthalmological preparations > Miotics and antiglaucoma medicines Ophthalmological preparations > Miotics and antiglaucoma medicines 1 Primary open-angle glaucoma 1 S01EE01 Local > Ophthalmological > Solution (eye drops): 50 µg per mL eye drops false false https://list.essentialmeds.org/medicines/235 ledipasvir + sofosbuvir 2015 Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP51 Oral > Solid: 90 mg + 400 mg tablet false false https://list.essentialmeds.org/medicines/495 lenalidomide 2019 Immunomodulators Immunomodulators 1 Plasma cell myeloma 1 L04AX04 Oral > Solid: 25 mg true false https://list.essentialmeds.org/medicines/408 letrozole 2023 Ovulation inducers Ovulation inducers 1 Female infertility without specification whether primary or secondary 1 L02BG04 Oral > Solid > dosage form: 2.5 mg false false https://list.essentialmeds.org/medicines/917 leuprorelin 2015 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of breast; Malignant neoplasms of prostate 2 L02AE02 Parenteral > General injections > IM: 7.5 mg in prefilled syringe; 22.5 mg in prefilled syringe true false https://list.essentialmeds.org/medicines/113 levamisole 1987 Intestinal anthelminthics Intestinal anthelminthics 1 Ascariasis 1 P02CE01 Oral > Solid > tablet: 50 mg (as hydrochloride); 150 mg (as hydrochloride) false false https://list.essentialmeds.org/medicines/59 levetiracetam 2023 Antiseizure medicines Antiseizure medicines 1 Epilepsy or seizures; Status epilepticus 2 N03AX14 Oral > Liquid: 100 mg per mL Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg Parenteral > General injections > IV: 100 mg per mL in 5 mL ampoule or vial; 5 mg per mL in 100 mL bag; 10 mg per mL in 100 mL bag; 15 mg per mL in 100 mL bag false false https://list.essentialmeds.org/medicines/902 levodopa + benserazide 2021 Medicines for parkinsonism Medicines for parkinsonism 1 Parkinson disease 1 false false https://list.essentialmeds.org/medicines/642 levodopa + carbidopa 1977 Medicines for parkinsonism Medicines for parkinsonism 1 Parkinson disease 1 N04BA02 Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet false false https://list.essentialmeds.org/medicines/393 levofloxacin 1999 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J01MA12 Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 250 mg; 500 mg; 750 mg false false https://list.essentialmeds.org/medicines/353 levonorgestrel 1995 Oral hormonal contraceptives Oral hormonal contraceptives; Intrauterine devices 2 Contact with health services for postcoital contraception; Contact with health services for contraceptive management; Contact with health services for insertion of contraceptive device 3 G03AD01, G03AC03, G02BA03 Oral > Solid: 750 µg [2]; 1.5 mg [1] Oral > Solid: 30 µg; Intrauterine system with reservoir containing 52 mg of levonorgestrel. false false https://list.essentialmeds.org/medicines/186 levonorgestrel-releasing implant 2007 Implantable contraceptives Implantable contraceptives 1 Contact with health services for insertion of contraceptive device 1 G03AC03 Implant > Subdermal: 75 mg per rod (two-rods) false false https://list.essentialmeds.org/medicines/424 levothyroxine 1977 Thyroid hormones and antithyroid medicines Thyroid hormones and antithyroid medicines 1 Hypothyroidism 1 H03AA01 Oral > Solid: 50 µg (sodium salt); 100 µg (sodium salt); 25 µg (sodium salt) false false https://list.essentialmeds.org/medicines/199 lidocaine 1977 Antiarrhythmic medicines Antiarrhythmic medicines; Local anaesthetics 2 Ventricular tachyarrhythmia; Local anaesthetics 2 C01BB01, N01BB02 Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule (hydrochloride); Parenteral > Locoregional injections > Spinal anaesthesia: 5% in 2 mL ampoule (hydrochloride) + 7.5% glucose solution Parenteral > Locoregional injections > Other: 1% (hydrochloride); 2% (hydrochloride); 0.5% (hydrochloride) Local > Topical > unspecified: 2 to 4% (hydrochloride) false false https://list.essentialmeds.org/medicines/8 lidocaine + epinephrine 2002 Local anaesthetics Local anaesthetics 1 Local anaesthetics 1 N01BB52 Parenteral > Locoregional injections > Other: 1% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine; 2% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine Local > Dental > Cartridge: 2% (lidocaine hydrochloride) + 1:80 000 epinephrine false false https://list.essentialmeds.org/medicines/277 linezolid 2015 Reserve group antibiotics Reserve group antibiotics; Antituberculosis medicines 2 Methicillin resistant Staphylococcus aureus; Vancomycin resistant Staphylococcus aureus; Vancomycin resistant Enterococcus; Multi-drug resistant Mycobacterium tuberculosis 4 J01XX08 Parenteral > General injections > IV: 2 mg per mL in 300 mL bag Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 400 mg tablet; 600 mg tablet Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 600 mg; Oral > Solid > dispersible tablet: 150 mg (scored) Oral > Solid > tablet: 600 mg false false https://list.essentialmeds.org/medicines/345 liraglutide Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 false true https://list.essentialmeds.org/medicines/932 lisinopril + amlodipine 2019 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C09BB03 Oral > Solid: 10 mg + 5 mg; 20 mg + 5 mg; 20 mg + 10 mg false false https://list.essentialmeds.org/medicines/531 lisinopril + hydrochlorothiazide 2019 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C09BA03 Oral > Solid: 10 mg + 12.5 mg; 20 mg + 12.5 mg; 20 mg + 25 mg false false https://list.essentialmeds.org/medicines/532 lithium carbonate 1977 Medicines for bipolar disorders Medicines for bipolar disorders 1 Bipolar or related disorders 1 N05AN01 Oral > Solid: 300 mg false false https://list.essentialmeds.org/medicines/248 loperamide 2013 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care 1 Palliative care 1 A07DA03 Oral > Solid > dosage form: 2 mg false false https://list.essentialmeds.org/medicines/28 lopinavir + ritonavir 2002 Antiretrovirals > Protease inhibitors Antiretrovirals > Protease inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AR10 Oral > Solid > tablet: 100 mg + 25 mg tablet (heat-stable); 200 mg + 50 mg tablet (heat-stable) Oral > Solid > dosage form: 40 mg + 10 mg false false https://list.essentialmeds.org/medicines/453 loratadine 2013 Antiallergics and medicines used in anaphylaxis Antiallergics and medicines used in anaphylaxis 1 Allergic or hypersensitivity conditions of unspecified type 1 R06AX13 Oral > Liquid: 1 mg per mL Oral > Solid > tablet: 10 mg; 5 mg (chewable); 10 mg (chewable) false false https://list.essentialmeds.org/medicines/34 lorazepam 2009 Antiseizure medicines Antiseizure medicines; Medicines for anxiety disorders 2 Status epilepticus; Anxiety 2 N05BA06 Parenteral > General injections > IV: 2 mg per mL in 1 mL ampoule; 4 mg per mL in 1 mL ampoule false false https://list.essentialmeds.org/medicines/51 losartan 2017 Antihypertensive medicines Antihypertensive medicines; Medicines used in heart failure 2 Essential hypertension; Heart failure 2 C09CA01 Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet false false https://list.essentialmeds.org/medicines/141 lovastatin 2021 Lipid-lowering agents Lipid-lowering agents 1 Mixed hyperlipidaemia; Coronary atherosclerosis 2 false false https://list.essentialmeds.org/medicines/527 magnesium sulfate 1995 Antiseizure medicines Antiseizure medicines 1 Severe pre-eclampsia; Eclampsia 2 B05XA05 Parenteral > General injections > IV: 500 mg per mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume) Parenteral > General injections > IM: 500 mg per mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume) false false https://list.essentialmeds.org/medicines/52 malaria vaccine 2025 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain specified single infectious diseases 1 J07XA01 All vaccines should comply with the WHO requirements for biological substances. false false https://list.essentialmeds.org/medicines/969 mannitol 1977 Diuretics Diuretics 1 Ocular hypertension; Cerebral oedema 2 B05BC01 Parenteral > General injections > IV: 10% solution; 20% solution false false https://list.essentialmeds.org/medicines/177 measles vaccine 1977 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against measles alone 1 J07BD01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/209 mebendazole 1977 Intestinal anthelminthics Intestinal anthelminthics; Cysticidal medicines 2 Hookworm diseases; Trichuriasis; Ascariasis; Enterobiasis; Other specified echinococcosis 5 P02CA01 Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable) false false https://list.essentialmeds.org/medicines/60 medroxyprogesterone acetate 1984 Injectable hormonal contraceptives Injectable hormonal contraceptives; Progestogens 2 Contact with health services for reasons associated with reproduction; Excessive menstruation with irregular cycle 2 G03AC06, G03DA02 Parenteral > General injections > IM: 150 mg per mL in 1 mL vial Parenteral > General injections > SC: 104 mg per 0.65 mL in pre-filled syringe; 104 mg per 0.65 mL in single dose injection delivery system; Oral > Solid: 5 mg false false https://list.essentialmeds.org/medicines/189 mefloquine 1987 Antimalarial medicines > Medicines for chemoprophylaxis in travellers Antimalarial medicines > Medicines for chemoprophylaxis in travellers 1 Malaria due to Plasmodium falciparum 1 P01BC02 Oral > Solid > tablet: 250 mg (scored) (as hydrochloride) false false https://list.essentialmeds.org/medicines/379 meglumine antimoniate 1987 Antileishmaniasis medicines Antileishmaniasis medicines 1 Visceral leishmaniasis; Mucocutaneous leishmaniasis; Cutaneous leishmaniasis 3 P01CB01 Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule false false https://list.essentialmeds.org/medicines/370 meglumine iotroxate 1984 Diagnostic agents > Radiocontrast media Diagnostic agents > Radiocontrast media 1 X-ray contrast media, iodinated 1 V08AC02 Parenteral > General injections > IV: 5 to 8 g iodine (as meglumine) in 100 to 250 mL false false https://list.essentialmeds.org/medicines/169 melarsoprol 1977 Medicines for the treatment of 2nd stage African trypanosomiasis Medicines for the treatment of 2nd stage African trypanosomiasis 1 Gambiense trypanosomiasis; Rhodesiense trypanosomiasis 2 P01CD01 Parenteral > General injections > IV: 3.6% in 5 mL ampoule solution (180 mg of active compound) false false https://list.essentialmeds.org/medicines/389 melphalan 2019 Cytotoxic medicines Cytotoxic medicines 1 Plasma cell myeloma 1 L01AA03 Parenteral > General injections > IV: 50 mg in vial powder for injection Oral > Solid: 2 mg false false https://list.essentialmeds.org/medicines/556 meningococcal meningitis vaccine 1979 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against single bacterial diseases 1 J07AH01, J07AH02, J07AH03, J07AH04, J07AH05, J07AH06, J07AH07, J07AH08, J07AH09, J07AH10 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/438 mercaptopurine 1984 Cytotoxic medicines Cytotoxic medicines 1 Lymphoid leukaemia, not elsewhere classified; Acute myeloid leukaemia with recurrent genetic abnormalities; Langerhans cell histiocytosis 3 L01BB02 Oral > Liquid: 20 mg per mL Oral > Solid: 50 mg tablet true false https://list.essentialmeds.org/medicines/97 meropenem 2017 Watch group antibiotics Watch group antibiotics; Medicines for bacterial central nervous system infections; Antituberculosis medicines 3 Neonatal meningitis; Peritoneal abscess (severe); Neutropaenia (high-risk); Peritonitis (severe); Multi-drug resistant Mycobacterium tuberculosis 5 J01DH02 Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection false false https://list.essentialmeds.org/medicines/329 meropenem + vaborbactam 2019 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem-resistant Pseudomonas aeruginosa; Carbapenem resistant Acinetobacter baumannii; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli 5 J01DH52 Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection false false https://list.essentialmeds.org/medicines/396 mesalazine 2021 Anti-inflammatory medicines Anti-inflammatory medicines 1 Crohn disease site; Ulcerative colitis 2 false false https://list.essentialmeds.org/medicines/547 mesna 2009 Supportive medicines Supportive medicines 1 Rhabdomyosarcoma primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Osteosarcoma of bone or articular cartilage of unspecified sites; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis; Burkitt lymphoma including Burkitt leukaemia 7 V03AF01 Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 2 mL ampoule Oral > Solid > tablet: 400 mg; 600 mg Oral > Other: 600 mg Oral > Solid > tablet: 400 mg Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule Oral > Solid: 400 mg; 600 mg true false https://list.essentialmeds.org/medicines/98 metformin 1997 Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 A10BA02 Oral > Solid: 500 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/191 methadone 2005 Medicines for opioid use disorders Medicines for opioid use disorders; Opioid analgesics 2 Opioid dependence; Chronic cancer pain 2 N07BC02 Oral > Liquid: 5 mg per 5 mL (methadone hydrochloride); 10 mg per 5 mL (methadone hydrochloride); 5 mg per mL concentrate for oral liquid (methadone hydrochloride); 10 mg per mL concentrate for oral liquid (methadone hydrochloride); Oral > Liquid: 5 mg per 5 mL (methadone hydrochloride); 25 mg per 5 mL (methadone hydrochloride); 50 mg per 5 mL concentrate for oral liquid (methadone hydrochloride); 10 mg per mL concentrate for oral liquid (methadone hydrochloride) Oral > Solid > tablet: 5 mg (methadone hydrochloride); 10 mg (methadone hydrochloride) false false https://list.essentialmeds.org/medicines/18 methimazole 2019 Thyroid hormones and antithyroid medicines Thyroid hormones and antithyroid medicines 1 Thyrotoxicosis 1 H03BB02 Oral > Solid > tablet: 5 mg; 10 mg false false https://list.essentialmeds.org/medicines/506 methotrexate 1977 Cytotoxic medicines Cytotoxic medicines; Dermatological medicines > Medicines affecting skin differentiation and proliferation; Disease-modifying anti-rheumatic drugs (DMARDs); Medicines for juvenile joint diseases 4 Lymphoid leukaemia, not elsewhere classified; Acute myeloid leukaemia with recurrent genetic abnormalities; Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Osteosarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of breast; Malignant trophoblastic neoplasms of placenta; Psoriasis of unspecified type; Rheumatoid arthritis, serology unspecified; Juvenile idiopathic arthritis 12 L01BA01, L04AX03 Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection Oral > Solid: 2.5 mg (as sodium salt) Parenteral > General injections > IV: 50 mg in vial (as sodium salt); Oral > Solid > tablet: 2.5 mg (as sodium salt); 10 mg (as sodium salt); Oral > Solid > tablet: 2.5 mg (as sodium salt) true false https://list.essentialmeds.org/medicines/99 methoxy polyethylene glycol-epoetin beta 2017 Antianaemia medicines Antianaemia medicines 1 Anaemia due to chronic disease 1 false true https://list.essentialmeds.org/medicines/419 methyldopa 1977 Antihypertensive medicines Antihypertensive medicines 1 Gestational hypertension 1 C02AB01 Oral > Solid: 250 mg false false https://list.essentialmeds.org/medicines/140 methylergometrine 2021 Uterotonics Uterotonics 1 Postpartum haemorrhage 1 false false https://list.essentialmeds.org/medicines/658 methylprednisolone 2011 Hormones and antihormones Hormones and antihormones 1 Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified 2 H02AB04 Parenteral > General injections > IV: 40 mg in vial (as sodium succinate); 125 mg in vial (as sodium succinate) Parenteral > General injections > IV: 40 mg in vial (as sodium succinate) powder for injection; 125 mg in vial (as sodium succinate) powder for injection true false https://list.essentialmeds.org/medicines/114 methylthioninium chloride 1979 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Acquired methaemoglobinaemia 1 V03AB17 Parenteral > General injections > IV: 10 mg per mL in 10 mL ampoule false false https://list.essentialmeds.org/medicines/38 meticillin 2023 Access group antibiotics Access group antibiotics 1 Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock 4 J01CF02 false false https://list.essentialmeds.org/medicines/818 metoclopramide 1982 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Antiemetic medicines 2 Palliative care; Nausea or vomiting 2 A03FA01 Oral > Liquid: 5 mg per 5 mL Oral > Solid: 10 mg (hydrochloride) Parenteral > General injections > unspecified: 5 mg per mL in 2 mL ampoule (hydrochloride); Oral > Liquid: 5 mg per 5 mL Oral > Solid: 10 mg (scored) (hydrochloride) Parenteral > General injections > unspecified: 5 mg per mL in 2 mL ampoule (hydrochloride) false false https://list.essentialmeds.org/medicines/29 metoprolol 2011 Antianginal medicines Antianginal medicines; Antihypertensive medicines; Antiarrhythmic medicines; Medicines used in heart failure 4 Angina pectoris; Essential hypertension; Cardiac arrhythmia; Heart failure 4 false false https://list.essentialmeds.org/medicines/497 metronidazole 1977 Antiamoebic and antigiardiasis medicines Antiamoebic and antigiardiasis medicines; Access group antibiotics 2 Amoebiasis; Trichomoniasis; Intestinal infections due to Clostridioides difficile; Necrotising fasciitis; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Other specified prophylactic measures 9 P01AB01, A01AB17, J01XD01 Oral > Liquid: 200 mg per 5 mL (as benzoate) Parenteral > General injections > unspecified: 500 mg in 100 mL vial Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg; Oral > Liquid: 200 mg per 5 mL (as benzoate) Local > Rectal > Suppository: 500 mg; 1 g Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg Oral > Solid > tablet: 500 mg; 200 mg; 250 mg; 400 mg Oral > Solid: 200 to 500 mg tablet Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection cefotaxime; ceftriaxone; cefazolin; ciprofloxacin false false https://list.essentialmeds.org/medicines/313 micafungin 2021 Antifungal medicines Antifungal medicines 1 Systemic or invasive candidosis 1 J02AX05 Parenteral > General injections > IV: 50 mg in vial (as sodium) powder for injection; 100 mg in vial (as sodium) powder for injection false false https://list.essentialmeds.org/medicines/621 miconazole 1977 Dermatological medicines > Antifungal medicines Dermatological medicines > Antifungal medicines 1 Fungal infection of the skin 1 D01AC02 Local > Topical > Cream: 2% (nitrate) Local > Topical > Ointment: 2% (nitrate) false false https://list.essentialmeds.org/medicines/149 midazolam 2009 Antiseizure medicines Antiseizure medicines; Medicines for other common symptoms in palliative care; Preoperative medication and sedation for short-term procedures 3 Status epilepticus; Palliative care; Sedative-hypnotic and anxiolytic drugs 3 N05CD08 Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial (for buccal administration); 5 mg per mL in 1 mL vial (for buccal administration); 5 mg per mL in 3 mL vial (for buccal administration) Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); Oral > Liquid: 2 mg per mL Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) Oral > Solid > dosage form: 7.5 mg; 15 mg; Parenteral > General injections > IV: 1 mg per mL in 5 vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Oral > Liquid: 2 mg per mL Oral > Solid > dosage form: 15 mg; 7.5 mg false false https://list.essentialmeds.org/medicines/11 mifepristone - misoprostol 2005 Medicines for medical abortion Medicines for medical abortion 1 Unspecified time of fetal death, cause not specified; Induced abortion 2 G03XB51 Oral > Solid > tablet: 200 mg + 200 µg; 200 mg [1] + 200 µg [4] in co-package false false https://list.essentialmeds.org/medicines/242 miltefosine 2011 Antileishmaniasis medicines Antileishmaniasis medicines 1 Visceral leishmaniasis; Cutaneous leishmaniasis; Mucocutaneous leishmaniasis 3 P01CX04 Oral > Solid: 10 mg; 50 mg false false https://list.essentialmeds.org/medicines/367 misoprostol 2005 Uterotonics Uterotonics; Medicines for medical abortion 2 Unspecified obstetric condition; Postpartum haemorrhage; Spontaneous abortion, incomplete, without complication 3 G02AD06 Local > Vaginal > tablet: 25 µg Oral > Solid: 200 µg; Oral > Solid > tablet: 200 µg false false https://list.essentialmeds.org/medicines/240 mometasone 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/667 mometasone + formoterol 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Asthma 1 false false https://list.essentialmeds.org/medicines/670 morphine 1977 Opioid analgesics Opioid analgesics; Preoperative medication and sedation for short-term procedures 2 Pain; Opioids or related analgesics and agents affecting opioid receptors 2 N02AA01 Oral > Liquid: 5 mg per 5 mL (morphine hydrochloride or morphine sulfate); 10 mg per 5 mL (morphine hydrochloride or morphine sulfate) Parenteral > General injections > unspecified: 1 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 2 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 10 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate) Oral > Solid > tablet: 10 mg immediate release (morphine sulfate) Oral > Solid > dosage form: 30 mg slow-release (morphine hydrochloride or morphine sulfate); 200 mg slow-release (morphine hydrochloride or morphine sulfate); 100 mg slow-release (morphine hydrochloride or morphine sulfate); 60 mg slow-release (morphine hydrochloride or morphine sulfate); 10 mg slow-release (morphine hydrochloride or morphine sulfate); 5 mg slow-release (morphine hydrochloride or morphine sulfate) Oral > Solid > granules: 20 mg (morphine sulfate); 30 mg (morphine sulfate); 60 mg (morphine sulfate); 100 mg (morphine sulfate); 200 mg (morphine sulfate); Parenteral > General injections > IV: 1 mg in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 2 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 10 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate) false false https://list.essentialmeds.org/medicines/12 moxidectin 2025 Antifilarials Antifilarials 1 Lymphatic filariasis; Onchocerciasis 2 Oral > Solid > tablet: 2 mg false false https://list.essentialmeds.org/medicines/963 moxifloxacin 2017 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis; Tuberculosis 2 J01MA14 Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 400 mg false false https://list.essentialmeds.org/medicines/354 mpox vaccine 2025 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BX01 All vaccines should comply with the WHO requirements for biological substances. false false https://list.essentialmeds.org/medicines/960 multiple micronutrient powder 2019 Vitamins and minerals Vitamins and minerals 1 Iron deficiency anaemia 1 A11AA01 Sachets containing: - iron (elemental) 12.5 mg (as coated ferrous fumarate) - zinc (elemental) 5 mg - vitamin A 300 micrograms - with or without other micronutrients at recommended daily values false false https://list.essentialmeds.org/medicines/546 multiple micronutrient supplement 2021 Other medicines administered to the mother Other medicines administered to the mother 1 Maternal care for other specified conditions predominantly related to pregnancy 1 A11AA01 Tablet containing: Vit A: 800 mcg retinol activity equivalent Vit C: 70 mg Vit D: 5 mcg (200 IU) Vit E: 10 mg alpha tocopherol equivalent Vit B1: 1.4 mg Vit B2: 1.4 mg Vit B3: 18 mg niacin equivalent Vit B6: 1.9 mg Folic acid: 400 mcg Vit B12: 2.6 mcg Iron: 30 mg Iodine: 150 mcg Zinc: 15 mg Selenium: 65 mcg Copper: 2 mg false false https://list.essentialmeds.org/medicines/624 mumps vaccine 1999 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against mumps alone 1 J07BE01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/220 mupirocin 1989 Dermatological medicines > Anti-infective medicines Dermatological medicines > Anti-infective medicines 1 Superficial bacterial folliculitis; Impetigo 2 D06AX09 Local > Topical > Cream: 2% (as mupirocin calcium) Local > Topical > Ointment: 2% false false https://list.essentialmeds.org/medicines/152 nadroparin 2015 Medicines affecting coagulation Medicines affecting coagulation 1 Acute ischaemic heart disease; Venous thromboembolism 2 false true https://list.essentialmeds.org/medicines/413 nafcillin 2023 Access group antibiotics Access group antibiotics 1 Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock 4 J01CF02 false false https://list.essentialmeds.org/medicines/751 naloxone 1977 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Unintentional exposure to or harmful effects of opioids or related analgesics 1 V03AB15 Parenteral > General injections > unspecified: 400 µg per 1 mL in ampoule (naloxone hydrochloride) false false https://list.essentialmeds.org/medicines/39 naltrexone 2023 Medicines for alcohol use disorders Medicines for alcohol use disorders 1 Disorders due to use of alcohol 1 N07BB04 Parenteral > General injections > IM: 380 mg in vial (extended-release) Oral > Solid > tablet: 50 mg false false https://list.essentialmeds.org/medicines/909 naproxen 2025 Medicines for acute migraine attacks Medicines for acute migraine attacks 1 Migraine 1 false false https://list.essentialmeds.org/medicines/977 natamycin 2017 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Infectious keratitis 1 S01AA10 Local > Ophthalmological > Suspension: 5% eye drops false false https://list.essentialmeds.org/medicines/230 neostigmine 1977 Muscle relaxants (peripherally-acting) and cholinesterase inhibitors Muscle relaxants (peripherally-acting) and cholinesterase inhibitors; Medicines for myasthenia gravis 2 Anticholinesterase reversible; Myasthenia gravis 2 N07AA01 Parenteral > General injections > unspecified: 0.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate) Oral > Solid > tablet: 15 mg (neostigmine bromide) false false https://list.essentialmeds.org/medicines/223 netilmicin 2021 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Other specified conjunctivitis; Infectious blepharitis 2 false false https://list.essentialmeds.org/medicines/653 nevirapine 1999 Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AG01 Oral > Liquid: 50 mg per 5 mL Oral > Solid > dispersible tablet: 50 mg Oral > Solid > tablet: 200 mg false false https://list.essentialmeds.org/medicines/451 niclosamide 1977 Intestinal anthelminthics Intestinal anthelminthics 1 Hymenolepiasis; Diphyllobothriasis; Taeniasis due to Taenia saginata; Taeniasis due to Taenia solium 4 P02DA01 Oral > Solid: 500 mg tablet (chewable) false false https://list.essentialmeds.org/medicines/61 nicotinamide 1979 Vitamins and minerals Vitamins and minerals 1 Pellagra 1 A11HA01 Oral > Solid: 50 mg false false https://list.essentialmeds.org/medicines/264 nicotine replacement therapy 2009 Medicines for nicotine use disorders Medicines for nicotine use disorders 1 Nicotine dependence 1 N07BA01 Local > Topical > Transdermal patch: 5 to 30 mg per 16 hour; 7 to 21 mg per 24 hour Oral > Solid > lozenge: 2 mg; 4 mg lozenge Local > Buccal > Oral spray: 1 mg per actuation Local > Buccal > Chewing gum: 2 mg; 4 mg false false https://list.essentialmeds.org/medicines/530 nifedipine 1987 Antioxytocics (tocolytics) Antioxytocics (tocolytics) 1 Preterm labour without delivery 1 C08CA05 Oral > Solid: 10 mg (immediate-release) false false https://list.essentialmeds.org/medicines/243 nifurtimox 1977 American trypanosomiasis American trypanosomiasis; Medicines for the treatment of 2nd stage African trypanosomiasis 2 Chagas disease; Gambiense trypanosomiasis 2 P01CC01 Oral > Solid > tablet: 30 mg (scored); 120 mg (scored) false false https://list.essentialmeds.org/medicines/390 nilotinib 2017 Targeted therapies Targeted therapies 1 Chronic myelogenous leukaemia, BCR-ABL1-positive 1 L01EA03 Oral > Solid > capsule: 150 mg; 200 mg true false https://list.essentialmeds.org/medicines/100 nilutamide 2021 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of prostate 1 true false https://list.essentialmeds.org/medicines/641 nitrofurantoin 1979 Access group antibiotics Access group antibiotics 1 Infectious cystitis 1 J01XE01 Oral > Liquid: 25 mg per 5 mL oral liquid Oral > Solid > dosage form: 100 mg; 50 mg false false https://list.essentialmeds.org/medicines/301 nitrous oxide 1977 General anaesthetics and oxygen > Inhalational medicines General anaesthetics and oxygen > Inhalational medicines 1 Anaesthetics and therapeutic gases 1 N01AX13 Respiratory > Inhalation: false false https://list.essentialmeds.org/medicines/3 nivolumab 2019 Immunomodulators Immunomodulators 1 Melanoma of skin 1 L01FF01 Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion; 10 mg per mL in 24 mL vial concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 24 mL vial concentrate solution for infusion; 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion true true https://list.essentialmeds.org/medicines/566 norethisterone 1977 Progestogens Progestogens 1 Excessive menstruation with irregular cycle 1 Oral > Solid: 5 mg false false https://list.essentialmeds.org/medicines/420 norethisterone enantate 1984 Injectable hormonal contraceptives Injectable hormonal contraceptives 1 Contact with health services for reasons associated with reproduction 1 G03AC01 Parenteral > General injections > IM: 200 mg per mL in 1 mL ampoule oily solution false false https://list.essentialmeds.org/medicines/190 normal immunoglobulin 1977 Human immunoglobulins Human immunoglobulins; Medicines for Guillain-Barré syndrome 2 Primary immunodeficiencies; Mucocutaneous lymph node syndrome; Langerhans cell histiocytosis; Acute inflammatory demyelinating polyneuropathy 4 J06BA02 Parenteral > General injections > IV: 5% protein solution; 10% protein solution Parenteral > General injections > IM: 16% protein solution Parenteral > General injections > SC: 15% protein solution; 16% protein solution; Parenteral > General injections > IV: 5% protein solution; 10% protein solution true true https://list.essentialmeds.org/medicines/465 nystatin 1979 Antifungal medicines Antifungal medicines 1 Candidosis 1 A07AA02 Oral > Liquid: 100000 IU per mL Local > Topical > Other: 100000 IU pessary Oral > Solid > dosage form: 500000 IU Oral > Solid > lozenge: 100000 IU false false https://list.essentialmeds.org/medicines/362 octreotide 2023 Medicines for disorders of the pituitary hormone system Medicines for disorders of the pituitary hormone system 1 Acromegaly or pituitary gigantism 1 H01CB02 Parenteral > General injections > IM: 20 mg in vial (modified-release, as acetate) plus diluent Parenteral > General injections > SC: 0.05 mg per mL in 1 mL vial (immediate-release, as acetate); 0.1 mg per mL in 1 mL vial (immediate-release, as acetate); 0.5 mg per mL in 1 mL vial (immediate-release, as acetate) false false https://list.essentialmeds.org/medicines/913 ofloxacin 1999 Ear, nose and throat medicines [c] Ear, nose and throat medicines [c]; Ophthalmological preparations > Anti-infective agents 2 Infectious diseases of external ear; Other specified conjunctivitis; Infectious keratitis 3 S01AE01 Local > Ophthalmological > Solution (eye drops): 0.3% false false https://list.essentialmeds.org/medicines/231 olanzapine 2023 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 N05AH03 Parenteral > General injections > IM: 10 mg in vial powder for injection false false https://list.essentialmeds.org/medicines/918 omeprazole 2009 Antiulcer medicines Antiulcer medicines 1 Gastrointestinal bleeding; Peptic ulcer, site unspecified; Gastro-oesophageal reflux disease 3 A02BC01 Parenteral > General injections > IV: 40 mg in vial Oral > Liquid: 1 mg per mL powder for oral liquid; 4 mg per mL powder for oral liquid Oral > Solid > dosage form: 10 mg; 20 mg; 40 mg false false https://list.essentialmeds.org/medicines/178 ondansetron 2009 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Antiemetic medicines 2 Palliative care; Nausea or vomiting 2 A04AA01 Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate); 2 mg per mL in 4 mL ampoule (as hydrochloride dihydrate) Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate) Oral > Solid: 4 mg (as hydrochloride dihydrate); 8 mg (as hydrochloride dihydrate); Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate); 2 mg per mL in 4 mL ampoule Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate) Oral > Solid > dosage form: 4 mg (as hydrochloride dihydrate); 8 mg (as hydrochloride dihydrate); 24 mg (as hydrochloride dihydrate) false false https://list.essentialmeds.org/medicines/30 oral rehydration salts 1977 Solutions correcting water, electrolyte and acid-base disturbances > Oral Solutions correcting water, electrolyte and acid-base disturbances > Oral; Oral rehydration 2 Other specified disorders of fluid, electrolyte or acid-base balance; Diarrhoea 2 A07CA Powder for dilution in 200 mL, 500 mL, 1 L: - glucose 75 mEq or mmol/L - sodium 75 mEq or mmol/L - chloride 65 mEq or mmol/L - potassium 20 mEq or mmol/L - citrate 10 mEq or mmol/L - osmolarity 245 mOsm/L - glucose 13.5 g/L - sodium chloride 2.6 g/L - potassium chloride 1.5 g/L - trisodium citrate dihydrate 2.9 g/L false false https://list.essentialmeds.org/medicines/540 oral rehydration salts - zinc sulfate 2019 Medicines used in diarrhoea Medicines used in diarrhoea 1 Diarrhoea 1 A07CA Oral > Other: ORS powder for dilution and zinc sulfate dispersible tablet 20 mg (co-packaged) false false https://list.essentialmeds.org/medicines/541 oseltamivir 2011 Other antivirals Other antivirals 1 Influenza due to identified seasonal influenza virus 1 J05AH02 Oral > Liquid: 6 mg per mL (as phosphate) powder for oral liquid Oral > Solid: 30 mg capsule (as phosphate); 45 mg capsule (as phosphate); 75 mg capsule (as phosphate) false false https://list.essentialmeds.org/medicines/291 oxacillin 2023 Access group antibiotics Access group antibiotics 1 Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock 4 J01CF02 false false https://list.essentialmeds.org/medicines/756 oxaliplatin 2015 Cytotoxic medicines Cytotoxic medicines 1 Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon 2 L01XA03 Parenteral > General injections > IV: 50 mg in vial powder for injection; 100 mg in vial powder for injection; 50 mg per 10 mL in 10 mL vial; 100 mg per 20 mL in 20 mL vial; 200 mg per 40 mL in 40 mL vial true false https://list.essentialmeds.org/medicines/101 oxamniquine 1977 Antischistosomals and other antitrematode medicines Antischistosomals and other antitrematode medicines 1 Schistosomiasis due to Schistosoma mansoni 1 P02BA02 Oral > Liquid: 250 mg per 5 mL Oral > Solid > capsule: 250 mg false false https://list.essentialmeds.org/medicines/66 oxycodone 2025 Opioid analgesics Opioid analgesics 1 Pain 1 false false https://list.essentialmeds.org/medicines/559 oxygen 1979 General anaesthetics and oxygen > Inhalational medicines General anaesthetics and oxygen > Inhalational medicines; Medical gases 2 Anaesthetics and therapeutic gases; Respiratory failure as acute or chronic 2 V03AN01 Respiratory > Inhalation: (medical gas); Respiratory > Inhalation: false false https://list.essentialmeds.org/medicines/4 oxytetracycline 2021 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Other specified conjunctivitis; Infectious keratitis; Infectious blepharitis; Trachoma 4 false false https://list.essentialmeds.org/medicines/656 oxytocin 1977 Uterotonics Uterotonics 1 Postpartum haemorrhage 1 H01BB02 Parenteral > General injections > unspecified: 10 IU per mL false false https://list.essentialmeds.org/medicines/241 p-aminosalicylate sodium 2023 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J04AA01 Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution false false https://list.essentialmeds.org/medicines/904 paclitaxel 2011 Cytotoxic medicines Cytotoxic medicines 1 Malignant neoplasms of cervix uteri; Kaposi sarcoma of unspecified primary site; Other specified malignant neoplasms of the ovary; Malignant neoplasms of nasopharynx; Other specified carcinomas of ovary; Other specified malignant neoplasms of bronchus or lung; Other specified malignant neoplasms of breast; Malignant neoplasms of breast 8 L01CD01 Parenteral > General injections > IV: 6 mg per mL true false https://list.essentialmeds.org/medicines/102 paliperidone 2021 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 N05AX13 Parenteral > General injections > IM: 25 mg in pre-filled syringe (as palmitate); 50 mg in pre-filled syringe (as palmitate); 75 mg in pre-filled syringe (as palmitate); 100 mg in pre-filled syringe (as palmitate); 150 mg in pre-filled syringe (as palmitate) false false https://list.essentialmeds.org/medicines/623 palonosetron 2025 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Antiemetic medicines 2 Palliative care; Nausea or vomiting 2 false false https://list.essentialmeds.org/medicines/631 pancreatic enzymes 2009 Gastrointestinal medicines Gastrointestinal medicines; Medicines for cystic fibrosis 2 Enzyme intestinal; Cystic fibrosis 2 A09AA02 Capsule (modified release): 10 000 lipase units + 8000 amylase units + 600 protease units; 25 000 lipase units + 18 000 amylase units + 1000 protease units. *Units expressed in Ph. Eur false false https://list.essentialmeds.org/medicines/514 paracetamol (acetaminophen) 1977 Medicines for acute migraine attacks Medicines for acute migraine attacks; Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) 2 Migraine; Pain 2 N02BE01 Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL Local > Rectal > Suppository: 250 mg Oral > Solid > dispersible tablet: 100 mg; 250 mg Oral > Solid > tablet: 250 mg; 325 mg; 500 mg; Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL Local > Rectal > Suppository: 100 mg; 250 mg Oral > Solid > dispersible tablet: 100 mg; 250 mg Oral > Solid > tablet: 250 mg; 325 mg; 500 mg false false https://list.essentialmeds.org/medicines/15 paromomycin 1977 Antileishmaniasis medicines Antileishmaniasis medicines 1 Visceral leishmaniasis 1 A07AA06 Parenteral > General injections > IM: 750 mg paromomycin base (as sulfate) false false https://list.essentialmeds.org/medicines/368 paroxetine 2023 Medicines for anxiety disorders Medicines for anxiety disorders 1 Generalised anxiety disorder 1 false false https://list.essentialmeds.org/medicines/662 pegaspargase 2019 Cytotoxic medicines Cytotoxic medicines 1 Lymphoid leukaemia, not elsewhere classified 1 L01XX24 Parenteral > General injections > IV: 3750 units per 5 mL in vial; 3750 units in vial powder for injection true true https://list.essentialmeds.org/medicines/558 pegfilgrastim 2023 Immunomodulators Immunomodulators 1 Acquired neutropaenia 1 L03AA13 Parenteral > General injections > SC: 6 mg per 0.6 mL in pre-filled syringe true true https://list.essentialmeds.org/medicines/907 pembrolizumab 2025 Immunomodulators Immunomodulators 1 Melanoma of skin; Other specified malignant neoplasms of large intestine; Malignant neoplasms of cervix uteri; Other specified malignant neoplasms of bronchus or lung 4 L01FF02 Parenteral > General injections > IV: 25 mg per mL in 4 mL vial Parenteral > General injections > IV: 25 mg per mL in 4 mL vial concentrate for solution for infusion Parenteral > General injections > IV: 25 mg per mL in 4 mL vial powder for injection true true https://list.essentialmeds.org/medicines/565 penicillamine 1979 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific; Disease-modifying anti-rheumatic drugs (DMARDs) 2 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified; Rheumatoid arthritis, serology unspecified 2 M01CC01 Oral > Solid: 250 mg false false https://list.essentialmeds.org/medicines/42 pentamidine 1977 Medicines for the treatment of 1st stage African trypanosomiasis Medicines for the treatment of 1st stage African trypanosomiasis; Antipneumocystosis and antitoxoplasmosis medicines 2 Gambiense trypanosomiasis; Pneumocystosis 2 P01CX01 Parenteral > General injections > IM: 300 mg in vial (as isetionate) powder for injection; Oral > Solid > tablet: 200 mg (as isethionate); 300 mg (as isethionate) false false https://list.essentialmeds.org/medicines/386 perindopril + amlodipine + indapamide 2025 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C09BX01 Oral > Solid > dosage form: 5 mg (arginine) + 5 mg + 1.25 mg; 5 mg (arginine) + 10 mg + 1.25 mg; 10 mg (arginine) + 5 mg + 2.5 mg; 10 mg (arginine) + 10 mg + 2.5 mg false false https://list.essentialmeds.org/medicines/961 permethrin 1989 Dermatological medicines > Scabicides and pediculicides Dermatological medicines > Scabicides and pediculicides 1 Pediculosis corporis; Pediculosis capitis; Scabies 3 P03AC04 Local > Topical > Lotion: 1% Local > Topical > Cream: 5% false false https://list.essentialmeds.org/medicines/163 pertussis vaccine 1999 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against pertussis alone 1 J07AJ02 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/210 phenobarbital 1977 Antiseizure medicines Antiseizure medicines 1 Status epilepticus; Epilepsy or seizures 2 N03AA02 Parenteral > General injections > IV: 200 mg per mL (phenobarbital sodium); 30 mg per mL (phenobarbital sodium); 60 mg per mL (phenobarbital sodium) Oral > Liquid: 15 mg per 5 mL Oral > Solid > tablet: 15 mg; 30 mg; 60 mg; 100 mg false false https://list.essentialmeds.org/medicines/53 phenoxymethylpenicillin 1977 Access group antibiotics Access group antibiotics 1 Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Periapical abscess without sinus; Acute pharyngitis 3 J01CE02 Oral > Liquid: 250 mg per 5 mL (as potassium salt) powder for oral liquid Oral > Solid: 250 mg (as potassium salt); 500 mg (as potassium salt) Oral > Solid: 250 mg (as potassium salt) tablet false false https://list.essentialmeds.org/medicines/308 phenytoin 1977 Antiseizure medicines Antiseizure medicines 1 Epilepsy or seizures 1 N03AB02 Oral > Liquid: 30 mg per 5 mL (phenytoin) Parenteral > General injections > unspecified: 50 mg per mL in vial (phenytoin sodium) Oral > Solid > tablet: 50 mg (phenytoin) (chewable) Oral > Solid > dosage form: 25 mg (phenytoin sodium); 50 mg (phenytoin sodium); 100 mg (phenytoin sodium) false false https://list.essentialmeds.org/medicines/54 phytomenadione 1977 Medicines affecting coagulation Medicines affecting coagulation 1 Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors; Haemorrhagic or haematological disorders of fetus or newborn 2 B02BA01 Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule; 2 mg per 0.2 mL in ampoule mixed micelle solution; 10 mg per mL in ampoule mixed micelle solution; 1 mg per 0.5 mL in ampoule Oral > Solid > tablet: 5 mg tablet false false https://list.essentialmeds.org/medicines/125 pilocarpine 1977 Ophthalmological preparations > Miotics and antiglaucoma medicines Ophthalmological preparations > Miotics and antiglaucoma medicines 1 Acute angle closure with pupillary block; Ocular hypertension; Primary open-angle glaucoma 3 S01EB01 Local > Ophthalmological > Solution (eye drops): 2% (hydrochloride or nitrate); 4% (hydrochloride or nitrate) false false https://list.essentialmeds.org/medicines/236 piperacillin + tazobactam 2017 Watch group antibiotics Watch group antibiotics 1 Other specified pneumonia (Hospital-acquired pneumonia); Necrotising fasciitis; Neutropaenia (high-risk); Peritoneal abscess (severe); Peritonitis (severe) 5 J01CR05 Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection clindamycin false false https://list.essentialmeds.org/medicines/320 platelets 2013 Blood and blood components Blood and blood components 1 Blood transfusion without reported diagnosis 1 B05AX02 Parenteral > General injections > IV: false true https://list.essentialmeds.org/medicines/456 plazomicin 2019 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem resistant Acinetobacter baumannii; Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Escherichia coli; Carbapenem resistant Klebsiella pneumoniae 5 J01GB14 Parenteral > General injections > IV: 500 mg per 10 mL false false https://list.essentialmeds.org/medicines/397 pneumococcal vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against single bacterial diseases 1 J07AL01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/211 podophyllotoxin 2021 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Plantar warts; Anogenital warts 2 false false https://list.essentialmeds.org/medicines/520 podophyllum resin 1984 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Plantar warts; Anogenital warts 2 D06BB04 Local > Topical > Solution: 10 to 25% false false https://list.essentialmeds.org/medicines/159 poliomyelitis vaccine 1977 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against poliomyelitis 1 J07BF01, J07BF02, J07BF03, J07BF04 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/212 polygeline 1989 Plasma substitutes Plasma substitutes 1 Hypovolaemia 1 Parenteral > General injections > IV: 3.5% injectable solution Parenteral > General injections > IV: 3.5% in solution false false https://list.essentialmeds.org/medicines/471 polymyxin B (injection) 2019 Reserve group antibiotics Reserve group antibiotics 1 Carbapenem-resistant Pseudomonas aeruginosa; Carbapenem resistant Acinetobacter baumannii; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli 5 J01XB02 Parenteral > General injections > IV: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base) false false https://list.essentialmeds.org/medicines/561 porcatant alfa 2009 Medicines administered to the neonate [c] Medicines administered to the neonate [c] 1 Respiratory distress syndrome of newborn 1 R07AA02 Respiratory > Suspension: 80 mg per mL for intratracheal instillation false false https://list.essentialmeds.org/medicines/989 potassium chloride 1977 Solutions correcting water, electrolyte and acid-base disturbances > Parenteral Solutions correcting water, electrolyte and acid-base disturbances > Parenteral; Solutions correcting water, electrolyte and acid-base disturbances > Oral 2 Hypokalaemia 1 B05XA01, A12BA01 Parenteral > General injections > IV: 11.2% in 20 mL ampoule (equivalent to K+ 1.5 mmol/mL and Cl- 1.5 mmol/mL); 7.5% solution for dilution (equivalent to K+ 1 mmol/mL and Cl- 2 mmol/mL); 15% solution for dilution (equivalent to K+ 2 mmol/mL and Cl- 2 mmol/mL); Oral > Liquid: powder for solution false false https://list.essentialmeds.org/medicines/255 potassium ferric hexacyanoferrate (Prussian blue) 1989 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 V03AB31 Oral > Solid: Powder for oral administration false false https://list.essentialmeds.org/medicines/43 potassium iodide 1977 Thyroid hormones and antithyroid medicines Thyroid hormones and antithyroid medicines; Antifungal medicines 2 Thyrotoxicosis; Sporotrichosis 2 V03AB21, D08AG03 Oral > Solid > tablet: 65 mg (scored); Local > Topical > Solution: Saturated solution false false https://list.essentialmeds.org/medicines/200 potassium permanganate 1995 Dermatological medicines > Anti-infective medicines Dermatological medicines > Anti-infective medicines 1 Tropical phagedaenic ulcer; Pemphigus; Other specified pyogenic bacterial infection of skin or subcutaneous tissue; Impetigo 4 D08AX06 Local > Topical > Solution: aqueous solution: 1:10 000 false false https://list.essentialmeds.org/medicines/153 povidone iodine 1993 Antiseptics Antiseptics 1 Povidone iodine 1 D08AG02 Local > Topical > Solution: 10% (equivalent to 1% available iodine) false false https://list.essentialmeds.org/medicines/172 pravastatin 2021 Lipid-lowering agents Lipid-lowering agents 1 Mixed hyperlipidaemia; Coronary atherosclerosis 2 false false https://list.essentialmeds.org/medicines/526 praziquantel 1979 Cysticidal medicines Cysticidal medicines; Antischistosomals and other antitrematode medicines; Intestinal anthelminthics 3 Cysticercosis of central nervous system; Paragonimiasis; Clonorchiasis; Opisthorchiasis; Schistosomiasis; Diphyllobothriasis; Taeniasis due to Taenia saginata; Hymenolepiasis; Taeniasis due to Taenia solium 9 P02BA01 Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg false false https://list.essentialmeds.org/medicines/62 precipitated sulfur 2021 Dermatological medicines > Scabicides and pediculicides Dermatological medicines > Scabicides and pediculicides 1 Pediculosis corporis; Pediculosis capitis; Pthiriasis; Scabies 4 Local > Topical > Ointment: false false https://list.essentialmeds.org/medicines/650 prednisolone 1984 Anti-inflammatory medicines Anti-inflammatory medicines; Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Ophthalmological preparations > Anti-inflammatory agents; Adrenal hormones and synthetic substitutes; Medicines for cluster headache; Antiseizure medicines 7 Crohn disease site; Ulcerative colitis; Lymphoid leukaemia, not elsewhere classified; Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Hodgkin lymphoma; Malignant neoplasms of prostate; Follicular lymphoma; Allergic or hypersensitivity conditions of unspecified type; Scleritis; Anterior uveitis; Adrenocortical insufficiency; Trigeminal autonomic cephalalgias; Infantile spasms 19 A07EA01, H02AB06, S01BA04 Local > Rectal > Retention enema: Local > Rectal > Retention enema: 20 mg per 100 mL (as sodium phosphate); Oral > Liquid: 5 mg per mL Oral > Solid: 5 mg; 25 mg; Local > Ophthalmological > Solution (eye drops): 0.5% (sodium phosphate); Oral > Solid > tablet: 1 mg; Oral > Solid > tablet: 5 mg; 25 mg; Oral > Liquid: 1 mg per mL Oral > Solid > tablet: 1 mg; 5 mg; 10 mg true false https://list.essentialmeds.org/medicines/35 prednisone 2021 Hormones and antihormones Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Adrenal hormones and synthetic substitutes 3 Lymphoid leukaemia, not elsewhere classified; Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Plasma cell myeloma; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Hodgkin lymphoma; Malignant neoplasms of prostate; Follicular lymphoma; Allergic or hypersensitivity conditions of unspecified type; Adrenocortical insufficiency 12 Oral > Solid > tablet: 1 mg true false https://list.essentialmeds.org/medicines/635 pretomanid 2023 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J04AK08 Oral > Solid > tablet: 200 mg false false https://list.essentialmeds.org/medicines/919 primaquine 1977 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium ovale; Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax 3 P01BA03 Oral > Solid > tablet: 7.5 mg (as phosphate); 15 mg (as phosphate) false false https://list.essentialmeds.org/medicines/380 procaine benzylpenicillin 2017 Access group antibiotics Access group antibiotics 1 Congenital syphilis [children]; Syphilis 2 J01CE09 Parenteral > General injections > IM: 1 g in vial (=1 million IU) powder for injection; 3 g in vial (=3 million IU) powder for injection false false https://list.essentialmeds.org/medicines/319 procarbazine 1979 Cytotoxic medicines Cytotoxic medicines 1 Hodgkin lymphoma 1 L01XB01 Oral > Solid: 50 mg (as hydrochloride) Oral > Solid > capsule: 50 mg (as hydrochloride) true false https://list.essentialmeds.org/medicines/103 progesterone vaginal ring 2015 Intravaginal contraceptives Intravaginal contraceptives 1 Contact with health services for contraceptive management 1 G03DA04 Local > Vaginal > vaginal ring: 2.074 g micronized progesterone false false https://list.essentialmeds.org/medicines/193 propanol 2021 Antiseptics Antiseptics 1 Denatured alcohol 1 false false https://list.essentialmeds.org/medicines/524 propofol 2011 General anaesthetics and oxygen > Injectable medicines General anaesthetics and oxygen > Injectable medicines 1 Anaesthetics and therapeutic gases 1 N01AX10 Parenteral > General injections > IV: 10 mg per mL; 20 mg per mL false false https://list.essentialmeds.org/medicines/6 propranolol 1977 Medicines for migraine prophylaxis Medicines for migraine prophylaxis 1 Migraine 1 C07AA05 Oral > Solid > tablet: 40 mg (hydrochloride); 10 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/392 propylthiouracil 1977 Thyroid hormones and antithyroid medicines Thyroid hormones and antithyroid medicines 1 Thyrotoxicosis 1 H03BA02 Oral > Solid: 50 mg false false https://list.essentialmeds.org/medicines/201 protamine sulfate 1977 Medicines affecting coagulation Medicines affecting coagulation 1 Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors 1 V03AB14 Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule or vial false false https://list.essentialmeds.org/medicines/126 protionamide 2025 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 Oral > Solid > tablet: 250 mg (scored) false false https://list.essentialmeds.org/medicines/637 pyrantel 1982 Intestinal anthelminthics Intestinal anthelminthics 1 Hookworm diseases; Trichuriasis; Ascariasis; Enterobiasis 4 P02CC01 Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate) false false https://list.essentialmeds.org/medicines/63 pyrazinamide 1982 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AK01 Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 400 mg; 500 mg false false https://list.essentialmeds.org/medicines/331 pyridostigmine 1977 Medicines for myasthenia gravis Medicines for myasthenia gravis; Muscle relaxants (peripherally-acting) and cholinesterase inhibitors 2 Myasthenia gravis 1 N07AA02 Parenteral > General injections > IV: 5 mg per mL in ampoule or vial (pyridostigmine bromide) Oral > Solid > tablet: 60 mg scored (pyridostigmine bromide) false false https://list.essentialmeds.org/medicines/204 pyridoxine 1977 Vitamins and minerals Vitamins and minerals 1 Other specified polyneuropathy; Vitamin B6 deficiency; Sideroblastic anaemia 3 A11HA02 Oral > Solid > tablet: 25 mg (hydrochloride); 10 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/265 pyrimethamine 1997 Antipneumocystosis and antitoxoplasmosis medicines Antipneumocystosis and antitoxoplasmosis medicines 1 Toxoplasmosis 1 P01BD01 Oral > Solid: 25 mg false false https://list.essentialmeds.org/medicines/384 quetiapine 2023 Medicines for psychotic disorders Medicines for psychotic disorders; Medicines for bipolar disorders 2 Schizophrenia or other primary psychotic disorders; Bipolar or related disorders 2 N05AH04 Oral > Solid > tablet: 25 mg (immediate-release); 100 mg (immediate-release); 150 mg (immediate-release); 200 mg (immediate-release); 300 mg (immediate-release); 50 mg (modified-release); 150 mg (modified-release); 200 mg (modified-release); 300 mg (modified-release); 400 mg (modified-release) false false https://list.essentialmeds.org/medicines/920 quinine 1977 Antimalarial medicines > Medicines for curative treatment Antimalarial medicines > Medicines for curative treatment 1 Malaria due to Plasmodium falciparum 1 P01BC01 Parenteral > General injections > IV: 300 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion; 60 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion false false https://list.essentialmeds.org/medicines/381 rabies vaccine 1977 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against rabies 1 J07BG01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/218 raltegravir 2017 Antiretrovirals > Integrase inhibitors Antiretrovirals > Integrase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AJ01 Oral > Liquid: 100 mg granules for oral suspension Oral > Solid: 400 mg tablet; 25 mg tablet (chewable) false false https://list.essentialmeds.org/medicines/289 ranitidine 2003 Antiulcer medicines Antiulcer medicines 1 Peptic ulcer, site unspecified; Gastro-oesophageal reflux disease 2 A02BA02 Oral > Liquid: 75 mg per 5 mL (as hydrochloride) Oral > Solid: 150 mg (as hydrochloride) Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (as hydrochloride) false false https://list.essentialmeds.org/medicines/179 rasburicase 2021 Supportive medicines Supportive medicines 1 Tumour lysis syndrome 1 V03AF07 Parenteral > General injections > IV: 1.5 mg in vial powder and 1 mL solvent for solution; 7.5 mg in vial powder and 5 mL solvent for solution true false https://list.essentialmeds.org/medicines/625 ravidasvir 2023 Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP13 Oral > Solid > tablet: 200 mg false false https://list.essentialmeds.org/medicines/899 ready to use therapeutic food 2023 Therapeutic foods Therapeutic foods 1 Acute malnutrition in infants, children or adolescents 1 Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines. false false https://list.essentialmeds.org/medicines/586 realgar-indigo naturalis formulation 2019 Cytotoxic medicines Cytotoxic medicines 1 Acute myeloid leukaemia with recurrent genetic abnormalities 1 Oral > Solid: 270 mg (containing tetra-arsenic tetra-sulfide 30 mg) false false https://list.essentialmeds.org/medicines/555 red blood cells 2013 Blood and blood components Blood and blood components 1 Blood transfusion without reported diagnosis 1 B05AX01 Parenteral > General injections > IV: false true https://list.essentialmeds.org/medicines/457 resin-based composite (high-viscosity) 2023 Dental medicines and preparations Dental medicines and preparations 1 Dental caries 1 Local > Topical > Other: Single-use capsule or multi-use syringe false false https://list.essentialmeds.org/medicines/923 resin-based composite (low-viscosity) 2023 Dental medicines and preparations Dental medicines and preparations 1 Dental caries 1 Local > Topical > Other: Single-use applicator or multi-use bottle false false https://list.essentialmeds.org/medicines/922 respiratory syncytial virus vaccine 2025 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BX05 All vaccines should comply with the WHO requirements for biological substances. false false https://list.essentialmeds.org/medicines/970 retinol 1977 Vitamins and minerals Vitamins and minerals 1 Vitamin A deficiency 1 A11CA01 Parenteral > General injections > IM: 50000 IU per mL in 2 mL ampoule or vial water-miscible (as palmitate) Oral > Liquid: 100000 IU per mL (as palmitate or acetate) Oral > Solid > capsule: 200000 IU (as palmitate or acetate) soft capsule; 50000 IU (as palmitate); 100000 IU (as palmitate or acetate) soft capsule false false https://list.essentialmeds.org/medicines/266 ribavirin 2007 Medicines for hepatitis C > Other antivirals for hepatitis C Medicines for hepatitis C > Other antivirals for hepatitis C 1 Chronic hepatitis C 1 J05AP01 Parenteral > General injections > IV: 1000 mg per 10 mL phosphate buffer solution; 800 mg per 10 mL phosphate buffer solution Oral > Solid: 200 mg; 400 mg; 600 mg false false https://list.essentialmeds.org/medicines/473 riboflavin 1979 Vitamins and minerals Vitamins and minerals 1 Vitamin B2 deficiency 1 A11HA04 Oral > Solid: 5 mg false false https://list.essentialmeds.org/medicines/267 rifabutin 2009 Antituberculosis medicines Antituberculosis medicines 1 Tuberculosis 1 J04AB04 Oral > Solid: 150 mg false false https://list.essentialmeds.org/medicines/335 rifampicin 1977 Antituberculosis medicines Antituberculosis medicines; Antileprosy medicines 2 Tuberculosis; Leprosy 2 J04AB02 Parenteral > General injections > IV: 600 mg in vial powder for injection Oral > Liquid: 20 mg per mL Oral > Solid: 150 mg; 300 mg; Oral > Liquid: 20 mg per mL Oral > Solid: 150 mg; 300 mg false false https://list.essentialmeds.org/medicines/294 rifapentine 2015 Antituberculosis medicines Antituberculosis medicines 1 Latent tuberculosis; Tuberculosis 2 J04AB05 Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 150 mg; 300 mg false false https://list.essentialmeds.org/medicines/336 risperidone 2013 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 N05AX08 Oral > Solid: 0.25 mg; 0.5 mg; 1 mg; 2 mg; 3 mg; 4 mg; 6 mg Parenteral > General injections > IM: false false https://list.essentialmeds.org/medicines/246 ritonavir 2002 Antiretrovirals > Protease inhibitors Antiretrovirals > Protease inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AE03 Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable) false false https://list.essentialmeds.org/medicines/461 rituximab 2015 Targeted therapies Targeted therapies; Medicines for multiple sclerosis 2 Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Burkitt lymphoma including Burkitt leukaemia; Follicular lymphoma; Multiple sclerosis 5 L01FA01 Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial; Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial true true https://list.essentialmeds.org/medicines/104 rivaroxaban 2019 Medicines affecting coagulation Medicines affecting coagulation 1 Other specified atrial fibrillation; Venous thromboembolism 2 false false https://list.essentialmeds.org/medicines/481 rotavirus vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BH01, J07BH02 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/213 rubella vaccine 1987 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against rubella alone 1 J07BJ01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/214 salbutamol 1977 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease; Asthma 2 R03AC02 Parenteral > General injections > IV: 500 µg per mL in 1 mL ampoule (as sulfate); 500 µg per mL in 5 mL ampoule (as sulfate) Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate); 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers false false https://list.essentialmeds.org/medicines/254 salicylic acid 1979 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Seborrhoeic dermatitis; Psoriasis of unspecified type; Ichthyoses 3 D01AE12 Local > Topical > Solution: 5% false false https://list.essentialmeds.org/medicines/160 selenium sulfide 1989 Dermatological medicines > Antifungal medicines Dermatological medicines > Antifungal medicines 1 Seborrhoeic dermatitis; Pityriasis versicolor 2 D01AE13 Local > Topical > Suspension: 2% detergent-based false false https://list.essentialmeds.org/medicines/150 semaglutide 2025 Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 A10BJ06 Parenteral > General injections > SC: 0.25 mg in pre-filled pen injection solution; 0.5 mg in pre-filled pen injection solution; 1 mg in pre-filled pen injection solution; 2 mg in pre-filled pen injection solution; 4 mg in pre-filled pen injection solution Oral > Solid > tablet: 3 mg Parenteral > General injections > SC: 0.68 mg per mL; 1.34 mg per mL; 2.68 mg per mL false true https://list.essentialmeds.org/medicines/973 senna 1977 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Laxatives 2 Palliative care; Constipation 2 A06AB06 Oral > Liquid: 7.5 mg per 5 mL oral liquid; Oral > Solid: 7.5 mg (sennosides) (or traditional dosage forms) false false https://list.essentialmeds.org/medicines/31 sertraline 2023 Medicines for anxiety disorders Medicines for anxiety disorders 1 Generalised anxiety disorder 1 false false https://list.essentialmeds.org/medicines/663 sevoflurane 2023 General anaesthetics and oxygen > Inhalational medicines General anaesthetics and oxygen > Inhalational medicines 1 Anaesthetics and therapeutic gases 1 N01AB08 Respiratory > Inhalation > liquid: false false https://list.essentialmeds.org/medicines/897 silver diamine fluoride 2021 Dental medicines and preparations Dental medicines and preparations 1 Dental caries 1 Local > Dental > Solution: 38% w/v false false https://list.essentialmeds.org/medicines/617 silver sulfadiazine 1987 Dermatological medicines > Anti-infective medicines Dermatological medicines > Anti-infective medicines 1 Burns 1 D06BA01 Local > Topical > Cream: 1% false false https://list.essentialmeds.org/medicines/154 simvastatin 2007 Lipid-lowering agents Lipid-lowering agents 1 Mixed hyperlipidaemia; Coronary atherosclerosis 2 C10AA01 Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg false false https://list.essentialmeds.org/medicines/148 sodium calcium edetate 1979 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 V03AB03 Parenteral > General injections > IV: 200 mg per mL in 5 mL ampoule false false https://list.essentialmeds.org/medicines/47 sodium chloride 1977 Solutions correcting water, electrolyte and acid-base disturbances > Parenteral Solutions correcting water, electrolyte and acid-base disturbances > Parenteral 1 Other specified disorders of fluid, electrolyte or acid-base balance 1 B05XA03 Parenteral > General injections > IV: 0.9% isotonic (equivalent to Na+ 154 mmol/L and Cl- 154 mmol/L) false false https://list.essentialmeds.org/medicines/258 sodium hydrogen carbonate 1977 Solutions correcting water, electrolyte and acid-base disturbances > Parenteral Solutions correcting water, electrolyte and acid-base disturbances > Parenteral 1 Acidosis 1 B05XA02 Parenteral > General injections > IV: 1.4% isotonic (equivalent to Na+ 167 mmol/L and HCO3- 167 mmol/L); 8.4% in 10 mL ampoule (equivalent to Na+ 1000 mmol/L and HCO3- 1000 mmol/L) false false https://list.essentialmeds.org/medicines/543 sodium nitrite 1979 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 V03AB08 Parenteral > General injections > IV: 30 mg per mL in 10 mL ampoule false false https://list.essentialmeds.org/medicines/44 sodium nitroprusside 1979 Antihypertensive medicines Antihypertensive medicines 1 Hypertensive crisis 1 C02DD01 Parenteral > General injections > IV: 50 mg in ampoule powder for infusion false false https://list.essentialmeds.org/medicines/142 sodium stibogluconate 1977 Antileishmaniasis medicines Antileishmaniasis medicines 1 Visceral leishmaniasis; Mucocutaneous leishmaniasis; Cutaneous leishmaniasis 3 P01CB02 Parenteral > General injections > unspecified: 100 mg per mL in 30 mL vial false false https://list.essentialmeds.org/medicines/369 sodium thiosulfate 1979 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific; Dermatological medicines > Antifungal medicines 2 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified; Pityriasis versicolor 2 V03AB06 Parenteral > General injections > IV: 250 mg per mL in 50 mL ampoule; Local > Topical > Solution: 15% false false https://list.essentialmeds.org/medicines/45 sofosbuvir 2015 Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP08 Oral > Solid > tablet: 200 mg; 400 mg Oral > Solid > granules: 200 mg in sachet false false https://list.essentialmeds.org/medicines/296 sofosbuvir + velpatasvir 2017 Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations 1 Chronic hepatitis C 1 J05AP55 Oral > Solid > tablet: 200 mg + 50 mg; 400 mg + 100 mg Oral > Solid > granules: 150 mg + 37.5 mg in sachet; 200 mg + 50 mg in sachet false false https://list.essentialmeds.org/medicines/290 spectinomycin 1982 Access group antibiotics Access group antibiotics 1 Gonococcal infection 1 J01XX04 Parenteral > General injections > unspecified: 2 g in vial (as hydrochloride) powder for injection false false https://list.essentialmeds.org/medicines/300 spironolactone 1977 Diuretics Diuretics; Medicines used in heart failure 2 Oedema; Ascites; Heart failure 3 C03DA01 Oral > Liquid: 25 mg per 5 mL Oral > Solid > tablet: 25 mg; 12.5 mg; Oral > Solid > tablet: 25 mg false false https://list.essentialmeds.org/medicines/144 streptokinase 1991 Thrombolytic medicines Thrombolytic medicines 1 Acute myocardial infarction 1 B01AD01 Parenteral > General injections > IV: 1.5 million IU in vial powder for injection false false https://list.essentialmeds.org/medicines/147 streptomycin (injection) 1977 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 J01GA01 Parenteral > General injections > IV: 1 g powder for injection (as sulfate) as vial false false https://list.essentialmeds.org/medicines/356 succimer 2011 Antidotes and other substances used in poisonings > Specific Antidotes and other substances used in poisonings > Specific 1 Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified 1 Oral > Solid: 100 mg false false https://list.essentialmeds.org/medicines/48 sulfadiazine 1977 Antipneumocystosis and antitoxoplasmosis medicines Antipneumocystosis and antitoxoplasmosis medicines 1 Toxoplasmosis 1 J01EC02 Oral > Solid: 500 mg false false https://list.essentialmeds.org/medicines/385 sulfadoxine + pyrimethamine 1979 Antimalarial medicines > Medicines for chemoprevention Antimalarial medicines > Medicines for chemoprevention 1 Malaria due to Plasmodium falciparum; Malaria 2 P01BD51 Oral > Solid: 500 mg + 25 mg tablet Oral > Solid > dispersible tablet: 250 mg + 12.5 mg tablet false false https://list.essentialmeds.org/medicines/382 sulfamethoxazole + trimethoprim 1977 Antipneumocystosis and antitoxoplasmosis medicines Antipneumocystosis and antitoxoplasmosis medicines; Access group antibiotics 2 Pneumocystosis; Infectious cystitis; Infectious gastroenteritis or colitis without specification of infectious agent 3 J01EE01 Parenteral > General injections > IV: 80 mg + 16 mg per mL in 5 mL ampoule; 80 mg + 16 mg per mL in 10 mL ampoule Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet Oral > Solid > dispersible tablet: 100 mg + 20 mg; Parenteral > General injections > IV: 80 mg + 16 mg per mL in 10 mL ampoule; 80 mg + 16 mg per mL in 5 mL ampoule Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet Oral > Solid > dispersible tablet: 100 mg + 20 mg Parenteral > General injections > IV: 80 mg + 16 mg per mL in 5 mL ampoule; 80 mg + 16 mg per mL in 10 mL ampoule false false https://list.essentialmeds.org/medicines/334 sulfasalazine 1977 Disease-modifying anti-rheumatic drugs (DMARDs) Disease-modifying anti-rheumatic drugs (DMARDs); Anti-inflammatory medicines 2 Rheumatoid arthritis, serology unspecified; Crohn disease site; Ulcerative colitis 3 A07EC01 Oral > Solid: 500 mg; Oral > Solid: 500 mg Local > Rectal > Suppository: 500 mg Local > Rectal > Retention enema: 3 g per 100 mL false false https://list.essentialmeds.org/medicines/180 sumatriptan 2021 Medicines for cluster headache Medicines for cluster headache; Medicines for acute migraine attacks 2 Trigeminal autonomic cephalalgias; Migraine 2 N02CC01 Parenteral > General injections > SC: 6 mg per 0.5 mL in pre-filled pen; 6 mg per 0.5 mL in pre-filled syringe; Oral > Solid > tablet: 50 mg false false https://list.essentialmeds.org/medicines/571 sunscreen, broad-spectrum 2025 Dermatological medicines > Sunscreens Dermatological medicines > Sunscreens 1 Albinism or other specified genetically-determined hypomelanotic disorders 1 Topical: Therapeutic broad-spectrum sunscreens should contain proven active ingredients in appropriate amounts to absorb or filter UVA and UVB radiation, and have a high sun protection factor (SPF). false false https://list.essentialmeds.org/medicines/943 suramin sodium 1977 Medicines for the treatment of 1st stage African trypanosomiasis Medicines for the treatment of 1st stage African trypanosomiasis 1 Rhodesiense trypanosomiasis 1 P01CX02 Parenteral > General injections > IV: 1 g in vial false false https://list.essentialmeds.org/medicines/387 suxamethonium 1977 Muscle relaxants (peripherally-acting) and cholinesterase inhibitors Muscle relaxants (peripherally-acting) and cholinesterase inhibitors 1 Muscle relaxants 1 M03AB01 Parenteral > General injections > IV: 50 mg per mL in 2 mL ampoule (chloride) false false https://list.essentialmeds.org/medicines/224 tacalcitol 2021 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Psoriasis of unspecified type 1 false false https://list.essentialmeds.org/medicines/610 tacrolimus 2021 Immunomodulators for non-malignant disease Immunomodulators for non-malignant disease 1 Failure or rejection of transplanted organs or tissues 1 L04AD02 Parenteral > General injections > IV: 5 mg per mL in 1 mL vial Oral > Liquid: 0.2 mg granules for oral suspension; 1 mg granules for oral suspension Oral > Solid: 0.5 mg (immediate-release); 0.75 mg (immediate-release); 1 mg (immediate-release); 2 mg (immediate-release); 5 mg (immediate-release) false false https://list.essentialmeds.org/medicines/553 tamoxifen 1984 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of breast; Other specified malignant neoplasms of breast 2 L02BA01 Oral > Solid: 10 mg (as citrate); 20 mg (as citrate) true false https://list.essentialmeds.org/medicines/115 tedizolid 2023 Reserve group antibiotics Reserve group antibiotics 1 Methicillin resistant Staphylococcus aureus; Vancomycin resistant Staphylococcus aureus; Vancomycin resistant Enterococcus 3 false false https://list.essentialmeds.org/medicines/784 telmisartan + amlodipine 2019 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C09DB04 Oral > Solid: 40 mg + 5 mg; 80 mg + 5 mg; 80 mg + 10 mg false false https://list.essentialmeds.org/medicines/533 telmisartan + hydrochlorothiazide 2019 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C09DA07 Oral > Solid: 40 mg + 12.5 mg; 80 mg + 12.5 mg; 80 mg + 25 mg false false https://list.essentialmeds.org/medicines/534 tenofovir disoproxil fumarate 2007 Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors; Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors 2 Contact with or exposure to human immunodeficiency virus; Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified; Chronic hepatitis B 3 J05AF07 Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil) false false https://list.essentialmeds.org/medicines/365 terbinafine 2011 Dermatological medicines > Antifungal medicines Dermatological medicines > Antifungal medicines 1 Fungal infection of the skin 1 D01AE15 Local > Topical > Cream: 1% terbinafine hydrochloride Local > Topical > Ointment: 1% terbinafine hydrochloride false false https://list.essentialmeds.org/medicines/151 terbutaline 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease; Asthma 2 false false https://list.essentialmeds.org/medicines/673 terizidone 2025 Antituberculosis medicines Antituberculosis medicines 1 Multi-drug resistant Mycobacterium tuberculosis 1 Oral > Solid > capsule: 250 mg false false https://list.essentialmeds.org/medicines/636 testosterone 1977 Androgens Androgens 1 Testicular dysfunction or testosterone-related disorders 1 G03BA03 Parenteral > General injections > IM: 200 mg per mL in 1 mL ampoule (enantate) false false https://list.essentialmeds.org/medicines/183 tetanus vaccine 1977 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against tetanus alone 1 J07AM01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/215 tetracaine 1977 Ophthalmological preparations > Local anaesthetics Ophthalmological preparations > Local anaesthetics 1 Local anaesthetics 1 S01HA03 Local > Ophthalmological > Solution (eye drops): 0.5% (hydrochloride) false false https://list.essentialmeds.org/medicines/233 tetracycline 1977 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Other specified conjunctivitis; Infectious keratitis; Infectious blepharitis; Trachoma 4 S01AA09 Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride) false false https://list.essentialmeds.org/medicines/232 thalidomide 2019 Immunomodulators Immunomodulators 1 Plasma cell myeloma 1 L04AX02 Oral > Solid: 50 mg true false https://list.essentialmeds.org/medicines/409 thiamine 1979 Vitamins and minerals Vitamins and minerals 1 Vitamin B1 deficiency 1 A11DA01 Parenteral > General injections > IV: 50 mg per mL in ampoule or vial (hydrochloride) Oral > Solid > tablet: 50 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/269 thiopental 2021 General anaesthetics and oxygen > Injectable medicines General anaesthetics and oxygen > Injectable medicines 1 Anaesthetics and therapeutic gases 1 false false https://list.essentialmeds.org/medicines/628 tick-borne encephalitis vaccine 2015 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against arthropod-borne viral encephalitis 1 J07BA01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/437 timolol 1984 Ophthalmological preparations > Miotics and antiglaucoma medicines Ophthalmological preparations > Miotics and antiglaucoma medicines 1 Ocular hypertension; Primary open-angle glaucoma 2 S01ED01 Local > Ophthalmological > Solution (eye drops): 0.25% (hydrogen maleate); 0.5% (hydrogen maleate) false false https://list.essentialmeds.org/medicines/237 tinidazole 2023 Antiamoebic and antigiardiasis medicines Antiamoebic and antigiardiasis medicines 1 Amoebiasis 1 false false https://list.essentialmeds.org/medicines/639 tioguanine 2011 Cytotoxic medicines Cytotoxic medicines 1 Lymphoid leukaemia, not elsewhere classified 1 L01BB03 Oral > Solid: 40 mg true false https://list.essentialmeds.org/medicines/105 tiotropium bromide 2019 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease 1 R03BB04 Respiratory > Inhalation > powder: 18 µg in capsule Respiratory > Inhalation > solution: 1.25 µg per actuation in soft mist inhaler; 2.5 µg per actuation in soft mist inhaler false false https://list.essentialmeds.org/medicines/539 tirzepatide Hypoglycaemic agents Hypoglycaemic agents 1 Type 2 diabetes mellitus 1 false true https://list.essentialmeds.org/medicines/976 tobramycin 2021 Ophthalmological preparations > Anti-infective agents Ophthalmological preparations > Anti-infective agents 1 Other specified conjunctivitis; Infectious blepharitis 2 false false https://list.essentialmeds.org/medicines/654 torasemide 2023 Diuretics Diuretics; Medicines used in heart failure 2 Anuria or oliguria; Oedema; Heart failure 3 false false https://list.essentialmeds.org/medicines/649 tranexamic acid 2011 Other medicines administered to the mother Other medicines administered to the mother; Medicines affecting coagulation 2 Postpartum haemorrhage; Haemorrhage, not elsewhere classified 2 B02AA02 Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule false false https://list.essentialmeds.org/medicines/127 trastuzumab 2015 Targeted therapies Targeted therapies 1 Carcinoma of breast, specialised type 1 L01FD01 Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection true true https://list.essentialmeds.org/medicines/106 triamcinolone hexacetonide 2023 Medicines for juvenile joint diseases Medicines for juvenile joint diseases 1 Juvenile idiopathic arthritis 1 H02AB08 Parenteral > Locoregional injections > Intra-articular: 20 mg per mL in vial false false https://list.essentialmeds.org/medicines/893 triclabendazole 1997 Antischistosomals and other antitrematode medicines Antischistosomals and other antitrematode medicines 1 Paragonimiasis; Fascioliasis 2 P02BX04 Oral > Solid > tablet: 250 mg (scored) false false https://list.essentialmeds.org/medicines/65 trihexyphenidyl 1977 Medicines for parkinsonism Medicines for parkinsonism 1 Parkinson disease 1 false false https://list.essentialmeds.org/medicines/410 trimethoprim 1987 Access group antibiotics Access group antibiotics 1 Infectious cystitis 1 J01EA01 Oral > Liquid: 50 mg per mL Oral > Solid: 100 mg; 200 mg false false https://list.essentialmeds.org/medicines/599 triptorelin 2021 Hormones and antihormones Hormones and antihormones 1 Malignant neoplasms of breast; Malignant neoplasms of prostate 2 true false https://list.essentialmeds.org/medicines/874 tropicamide 1987 Diagnostic agents > Ophthalmic medicines Diagnostic agents > Ophthalmic medicines 1 Cycloplegic drug 1 S01FA06 Local > Ophthalmological > Solution (eye drops): 0.5% false false https://list.essentialmeds.org/medicines/165 tropisetron 2025 Medicines for other common symptoms in palliative care Medicines for other common symptoms in palliative care; Antiemetic medicines 2 Palliative care; Nausea or vomiting 2 false false https://list.essentialmeds.org/medicines/632 tuberculin, purified protein derivative 1977 Immunologicals > Diagnostic agents Immunologicals > Diagnostic agents 1 Mycobacterial diseases 1 V04CF01 Parenteral > Locoregional injections > Intradermal: false false https://list.essentialmeds.org/medicines/203 typhoid vaccine 1977 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against typhoid-paratyphoid alone 1 J07AP03 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/219 ulipristal 2017 Oral hormonal contraceptives Oral hormonal contraceptives 1 Contact with health services for postcoital contraception 1 G03AD02 Oral > Solid: 30 mg tablet (ulipristal acetate) false false https://list.essentialmeds.org/medicines/187 umeclidinium 2025 Antiasthmatic and medicines for chronic obstructive pulmonary disease Antiasthmatic and medicines for chronic obstructive pulmonary disease 1 Chronic obstructive pulmonary disease 1 false false https://list.essentialmeds.org/medicines/676 urea 1995 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation; Dermatological medicines > Moisturizers 2 Xerosis cutis or asteatosis; Atopic eczema 2 D02AE01 Local > Topical > Cream: 10%; 5% Local > Topical > Ointment: 10%; 5%; Local > Topical > Cream: 5 per % false false https://list.essentialmeds.org/medicines/161 ustekinumab 2025 Dermatological medicines > Medicines affecting skin differentiation and proliferation Dermatological medicines > Medicines affecting skin differentiation and proliferation 1 Psoriasis of unspecified type 1 L04AC05 Parenteral > General injections > SC: 45 mg per 0.5 mL in vial; 45 mg per 0.5 mL in pre-filled syringe; 45 mg per 0.5 mL in pre-filled pen; 90 mg per mL in pre-filled syringe; 90 mg per mL in pre-filled pen false true https://list.essentialmeds.org/medicines/946 valaciclovir 2025 Medicines for viral central nervous system infections Medicines for viral central nervous system infections 1 Zoster; Herpes simplex infections; Varicella 3 false false https://list.essentialmeds.org/medicines/563 valganciclovir 2015 Other antivirals Other antivirals 1 Cytomegaloviral retinitis 1 J05AB14 Oral > Liquid: 50 mg per mL (as hydrochloride) powder for oral solution Oral > Solid > tablet: 450 mg (as hydrochloride) false false https://list.essentialmeds.org/medicines/474 valproic acid (sodium valproate) 1979 Antiseizure medicines Antiseizure medicines; Medicines for bipolar disorders 2 Epilepsy or seizures; Status epilepticus; Bipolar or related disorders 3 N03AG01 Oral > Liquid: 200 mg per 5 mL Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated); 100 mg tablet (crushable) Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 3 mL ampoule; Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated) false false https://list.essentialmeds.org/medicines/55 valsartan + amlodipine + hydrochlorothiazide 2025 Antihypertensive medicines Antihypertensive medicines 1 Essential hypertension 1 C09DX01 Oral > Solid > dosage form: 160 mg + 5 mg + 12.5 mg; 160 mg + 5 mg + 25 mg; 160 mg + 10 mg + 12.5 mg; 160 mg + 10 mg + 25 mg; 320 mg + 10 mg + 25 mg false false https://list.essentialmeds.org/medicines/962 vancomycin 1995 Watch group antibiotics Watch group antibiotics 1 Necrotising fasciitis; Endophthalmitis; Intestinal infections due to Clostridioides difficile; Neutropaenia (high-risk) 4 J01XA01, A07AA09 Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride) Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection ceftazidime; ceftriaxone false false https://list.essentialmeds.org/medicines/333 varenicline 2021 Medicines for nicotine use disorders Medicines for nicotine use disorders 1 Nicotine dependence 1 N07BA03 Oral > Solid: 0.5 mg; 1 mg false false https://list.essentialmeds.org/medicines/607 varicella vaccine 2007 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BK01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/221 vecuronium 1991 Muscle relaxants (peripherally-acting) and cholinesterase inhibitors Muscle relaxants (peripherally-acting) and cholinesterase inhibitors 1 Muscle relaxants 1 M03AC03 Parenteral > General injections > IV: 10 mg in vial powder for injection (vecuronium bromide) false false https://list.essentialmeds.org/medicines/225 verapamil 1982 Antianginal medicines Antianginal medicines; Medicines for cluster headache; Antiarrhythmic medicines 3 Angina pectoris; Trigeminal autonomic cephalalgias; Supraventricular tachyarrhythmia 3 C08DA01 Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride); Oral > Solid > tablet: 120 mg (hydrochloride) (immediate-release); 40 mg (hydrochloride) (immediate-release); 80 mg (hydrochloride) (immediate-release); 120 mg (hydrochloride) (extended-release); 180 mg (hydrochloride) (extended-release); 240 mg (hydrochloride) (extended-release); Parenteral > General injections > IV: 2.5 mg per mL in 2 mL ampoule (hydrochloride) Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride) false false https://list.essentialmeds.org/medicines/133 vinblastine 1984 Cytotoxic medicines Cytotoxic medicines 1 Other specified gliomas of brain; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Kaposi sarcoma of unspecified primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Hodgkin lymphoma 8 L01CA01 Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate) Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate) true false https://list.essentialmeds.org/medicines/107 vincristine 1977 Cytotoxic medicines Cytotoxic medicines 1 Other specified gliomas of brain; Diffuse large B-cell lymphoma, not otherwise specified; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Langerhans cell histiocytosis; Kaposi sarcoma of unspecified primary site; Rhabdomyosarcoma primary site; Hodgkin lymphoma; Malignant trophoblastic neoplasms of placenta; Follicular lymphoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Retinoblastoma; Malignant neoplasms of kidney, except renal pelvis 13 L01CA02 Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate) Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate) true false https://list.essentialmeds.org/medicines/108 vinorelbine 2015 Cytotoxic medicines Cytotoxic medicines 1 Rhabdomyosarcoma primary site; Other specified malignant neoplasms of bronchus or lung; Other specified malignant neoplasms of breast 3 L01CA04 Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial Oral > Solid > capsule: 20 mg; 30 mg; 80 mg Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial true false https://list.essentialmeds.org/medicines/109 voriconazole 2017 Antifungal medicines Antifungal medicines 1 Chronic pulmonary aspergillosis; Invasive aspergillosis 2 J02AC03 Parenteral > General injections > IV: 200 mg in vial powder for injection Oral > Liquid: 40 mg per mL powder for oral liquid Oral > Solid: 50 mg tablet; 200 mg tablet false false https://list.essentialmeds.org/medicines/288 warfarin 1977 Medicines affecting coagulation Medicines affecting coagulation 1 Venous thromboembolism; Cerebral ischaemic stroke due to embolic occlusion; Atrial fibrillation; Other specified diseases of arteries or arterioles 4 B01AA03 Oral > Solid > tablet: 5 mg (scored) (sodium); 1 mg (scored) (sodium); 2 mg (scored) (sodium); 0.5 mg (scored) (sodium); 3 mg (scored) (sodium) Oral > Solid > tablet: 5 mg (scored) (sodium); 1 mg (scored) (sodium); 2 mg (scored) (sodium); 0.5 mg (scored) (sodium); 3 mg (scored) (sodium) false false https://list.essentialmeds.org/medicines/128 water for injection 1977 Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous 1 Unspecified appropriateness of dosing or administration without injury or harm 1 Parenteral > General injections > unspecified: 2 mL ampoule; 5 mL ampoule; 10 mL ampoule false false https://list.essentialmeds.org/medicines/587 whole blood 2013 Blood and blood components Blood and blood components 1 Blood transfusion without reported diagnosis 1 Parenteral > General injections > IV: false true https://list.essentialmeds.org/medicines/459 xylometazoline 2009 Ear, nose and throat medicines [c] Ear, nose and throat medicines [c] 1 Nasal congestion 1 R01AA07 Local > Nasal > Spray: 0.05% equivalent to 0.5 mg per mL Local > Nasal > Drops: 0.05% equivalent to 0.5 mg per mL false false https://list.essentialmeds.org/medicines/272 yellow fever vaccine 1979 Immunologicals > Vaccines Immunologicals > Vaccines 1 Need for immunization against certain single viral diseases 1 J07BL01 All vaccines should comply with the WHO requirements for biological substances. false true https://list.essentialmeds.org/medicines/216 zanubrutinib Targeted therapies Targeted therapies 1 Chronic lymphocytic leukaemia or small lymphocytic lymphoma 1 Oral > Solid: 80 mg Oral > Solid > capsule: 80 mg true false https://list.essentialmeds.org/medicines/895 zidovudine 1997 Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors 1 Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified 1 J05AF01 Parenteral > General injections > IV: 10 mg per mL in 20 mL vial solution for IV infusion Oral > Liquid: 50 mg per 5 mL Oral > Solid > tablet: 300 mg Oral > Solid > capsule: 250 mg false false https://list.essentialmeds.org/medicines/366 zinc sulfate 2005 Medicines for diarrhoea Medicines for diarrhoea 1 Diarrhoea 1 A12CB01 Oral > Solid > dispersible tablet: 20 mg (scored) false false https://list.essentialmeds.org/medicines/181 zoledronic acid 2017 Supportive medicines Supportive medicines 1 Malignant neoplasm metastasis in bone or bone marrow 1 M05BA08 Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle true false https://list.essentialmeds.org/medicines/110 zuclopenthixol decanoate 2023 Medicines for psychotic disorders Medicines for psychotic disorders 1 Schizophrenia or other primary psychotic disorders 1 false false https://list.essentialmeds.org/medicines/925